Knowledge

Innate lymphoid cell

Source 📝

1692: 1073: 1534: 1438: 1330:. ILC2s promote the beiging of adipocytes, and therefore increased energy expenditure. Therefore, decreased responses of ILC2s in the tissue are a characteristic of obesity, as this interrupts their crucial role in energy homeostasis, resulting in reduced energy expenditure and increased adiposity. In addition to ILC2s, ILC1s contribute to the homeostasis of adipose tissue macrophages in both lean and obese conditions, making up 5-10% of the resident lymphocyte population, in human lean adipose depots. A high fat diet increases ILC1 number, and activation of adipose tissue, increasing IFN-γ and TNF-α levels. ILC1s produce the macrophage chemoattractant CCL2, and therefore ILC1- macrophage signalling is a key regulator of adipose tissue. This pathway could be a potential target for treating patients with 1553:. In addition, the number of ILC1s in the intestinal mucosa of patients with Crohn’s disease is increased from approximately 10% to 40% of the total ILCs present. The increase in ILCs present correlates with the severity of the disease. Evidence suggests that the plasticity between ILC3s and ILC1s in the intestine is an important factor of Crohn’s disease, with ILC3s differentiating into ILC1s when exposed to IL-12 produced by dendritic cells. However, IL-23, IL-1B and retinoic acid present in the intestine can drive the differentiation of ILC1s back to ILC3s. Evidence also suggests the ability of ILC2s to acquire the pro-inflammatory phenotype, with ILC2s producing IFN-γ present in the intestine of patients with Crohn’s disease, in response to certain environmental factors such as cytokines. 902:), critical in B and T cell development. Initially it was assumed that ID2 was required in order for CLPs to differentiate into all ILC subsets, however, research showed that knock out of ID2 during CLP development, cripples the development of all ILC subsets other than NK cell progenitors, which are not reliant on the presence of Id2. Due to this realisation, a group of lineage negative cells (requirement of any true precursor cell), that were entirely dependent on the presence of ID2, and expressed other key ILC markers, were identified, with the phenotype: Lin-ID2+IL7Ra+CD25-α4β7+, which are now known as the common helper like innate lymphoid progenitors CHILPs. They are named ‘common helper like’ due to their similarity to the T helper effector cell fates. 1643: 1499: 866: 1635: 1381: 1242: 1021: 743: 1704:(COPD) are a prototypical example of ILC plasticity. Studies in both humans and mice have shown lung resident ILC2s acquire an ILC1 phenotype during COPD, increasing IFN-γ secretion, and therefore inflammation. Various triggers, including cigarette smoke, cause secretion of IL-12 and IL-18, causing the differentiation ILC2s into ILC1s. GATA3 is down-regulated, and T-bet expression is up-regulated. Patients therefore have a higher blood ILC1:ILC2 ratio, with the abundance of ILC1s present correlating with the severity of the disease. 1084:, creating a network between the microbiota, and the host, favouring homeostasis. ILC3s restrict colonization of multiple unbeneficial bacteria in the gut, via secretion of IL-22, stimulating epithelial cells to produce antimicrobial peptides. The IL-22 production is induced due to the production of IL-23 and IL-1β by macrophages and DCs, and it promotes mucosal layer healing. For example, IL-22 can promote repair of intestinal damage after 1666:
Interestingly, it has been suggested that Th17 and Tfh inflammatory responses are generated in the gastrointestinal tract and that microbiota can increase this response. Thus the development of ILCs implicated in regulating the immune response against the microbiota in the intestine has been associated with arthritis. In case of ILC2 has an important role in regulating inflammatory responses by producing IL-4, IL-9, and IL-13.
313: 252: 376: 1688:
common feature in T cells, and it is believed this plasticity is critical to allow our immune system to fine tune responses to so many different pathogens. ILC plasticity requires cytokine receptors, their transcription factors, and access of defined chromatin regions to the transcription factors, however, it still remains unclear where these cytokines are produced and where the differentiation occurs in Vivo.
1720:
inflammatory events. Although the plasticity is reversible, during the differentiation of NKp46+ ILC3s to ILC1, the modulation of the expression of T-bet depends on IL-23, IL-2, and IL-1b and is improved by retinoic acid. Therefore, ILC3 to ILC1 plasticity depends on dendritic cells that produce these cytokines. Although the interconversion of ILC1 and ILC3 is modulated by the differential expression of
191: 767:. They are critical during both the embryonic and adult stages of development of the immune system, and therefore LTi cells are present in organs and tissues early during embryonal development. They have a pivotal role in primary and secondary lymphoid tissue organisation and in adult lymphoid tissue, regulating the adaptive immune response and maintaining secondary lymphoid tissue structures. 1003:. In the intestine, in response to a helminth infection, epithelial cells secrete high levels of IL-25, activating ILC2 cells. ILC2s produce IL-13, which drives the differentiation of additional epithelial cells, via Notch signalling pathways. This instruction allows the tissue to be remodelled to allow for the expulsion of the helminth parasite, and other large pathogens. 1453:, and viruses. These cytokines activate ILC2s, and therefore, an increased number of ILC2s, and type-2 cytokines (IL-4/5/13) are present in patients with allergic asthma. They secrete IL-13, initiating allergic lung inflammation, and additionally promote Th2 differentiation, increasing the production of IL-13, and therefore amplifying the allergic response. 1108:, promoting tolerance to beneficial commensals. The relationship between ILC3s, and T cells in the gut is therefore crucial for maintaining homeostasis, as in the absence of ILC3s, there could be uncontrolled T cell activation. In addition, microbiota play a role in fine tuning IL-22 production by ILC3s, for example, segmented filamentous bacteria in the 1653:, another inflammatory skin disease, causes epidermal thickening, forming plaques which are mainly populated with T cells and dendritic cells. The T cells portray a type 1 immune response; however, the thickening and inflammation of the epidermis is thought to be caused by the production of IL-22, IL-17A, and IL-17F by other T cells such as Th17 or 1457:
ILC2s present correlates with the severity of the disease, and evidence confirms some ‘allergen- experienced’ ILC2s persist after the resolution of the initial inflammation, portraying similarities to memory T cells. The presence of the ‘allergen- experienced’ ILC2s may be the reason asthmatic patients are often sensitised to various allergens.
1415:
vessels and airways. In addition, IL-5-producing ILC2s are found in pulmonary neuroendocrine cells in the airway branch junctions at which particles entering the airways become concentrated. The localization of ILC2 in the airways suggests that the residency of ILC2 is defined by microenvironments in different zones of the tissue.
1147:
expression of gut homing receptors on ILC1s, and ILC3s, and enhances ILC3 function, by upregulating RORγt, and IL-22. There is also crosstalk between macrophages and ILC3s, via RORγt driven GM-CSF production, that is dependent on microbial signalling, and the production of IL-1β by macrophages. A deficiency in dietary
938:. The coordinated expression of these specific transcription factors activate or repress target genes critical in the differentiation of the lymphocyte subsets. In particular, Nfil3, whose expression is regulated by cytokines, controls the differentiation of ILCs via the transcription factors Id2, RORγt, Eomes, and 1406:
of lymphocytes were identified as ILCs, most of them producing IFN-γ ILC1s. ILC3s in the oropharyngeal protect against the infection of Candida albicans producing IL-17A and IL-17F induced by IL-23. Mice lacking ILC3s due to the deletion of RORγt or depletion suffered severe infections by Candida albicans.
734:. NCR- ILC3s mainly produce IL-17A and IL-17F, and under certain circumstances, IL-22. NCR- ILC3s can differentiate into NCR+ upon increased expression levels of T-bet. Despite expressing NK cell markers, ILC3s differ greatly from NK cells, with different developmental pathways and effector functions. 1564:
NK cells secrete IFN-γ, which has anti-tumorigenic effects. Multiple studies show a decreased frequency of NK cells and IFN-γ present in the intestine or peripheral blood of patients with intestinal cancer. Further studies are required to address their exact role in the intestinal cancer environment.
1489:
Evidence suggests that targeting ILCs may be beneficial in the design of therapeutics for autoimmune disorders. As ILCs and T cells have many redundant functions, targeting and neutralizing their effector cytokines might be a better option. Alternatively, targeting their upstream activating mediators
651:
Although considered homogenous, ILC2s can be classified into subpopulations of natural ILC2s (nILC2s), and inflammatory ILC2s (iILC2s), dependent on their responsiveness to IL-33 and IL-25. nILC2s are those responsive to IL-33 in tissues in a natural immune state, while iILC2s respond to IL-25 or the
1758:
focused on the innate system’s nonspecific nature and lack of memory. As information has emerged about the functions of NK cells and other ILCs as effectors and orchestrators of the adaptive immune response, this distinction has become less clear. Some researchers suggest that the definition should
1727:
In the case of ILC2, Gata3 can be downregulated due to the exposure of infectious agents such as the influenza virus, respiratory syncytial virus, and Staphylococcus aureus, increasing the expression of IL12Rb2, IL-18Ra, and T-bet. The differentiation of ILC2 to ILC1 can also be reversible, although
1423:
The circadian clock and ILC interactions have been demonstrated by studying the regulation of the master gene clock Arntl. Its deletion resulted in the dysregulation of ILC3 caused by epigenetic changes, driving the expression of IL-22 and contributing to the alteration of the microbiome, epithelial
1414:
It has been shown that the ILCs can secrete neurotransmitters and neuropeptides in the lungs. ILC2s interact with neurons in the respiratory tract by the proximity to nerve fibers, and lung resident IL-5-producing ILC2s are found in collagen-rich regions close to the confluence of medium-sized blood
1308:
to induce IL-22 expression, maintaining the number of ILC3s present, and therefore intestinal homeostasis. The vitamin A metabolite, retinoic acid, also upregulates the expression of IL-22, and therefore, the absence of the AhR signalling pathway, and of retinoic acid, results in reduced immunity to
1146:
AHR ligands from diet or microbiota are recognised by immune cells, regulating ILC development and NK cell functions in the intestine. In response to tryptophan metabolites, AhR signalling maintains IL-22 expression and intestinal homeostasis. Retinoic acid, produced by dendritic cells, promotes the
1048:
In addition, ILC1s and ILC3s release oxygen radicals and lethally damaging enzymes in response to pathogenic infection, causing damage to the host tissue. The repair responses for the tissue are coordinated by the type 2 immune response, after the ILC3s and ILC1s have cleansed the tissue of microbes
1028:
In multiple tissue niches, ILCs have a relationship with non- hematopoietic cells such as stromal cells. In the lung, ILC2s have a distinct localization to stromal cells, which release IL-33, and TSLP, promoting ILC2 homeostasis, in both the steady state, and in response to helminth infection, after
1405:
The oral mucosa is colonized with commensals and is exposed to dietary antigens and pathogens. The ILCs in the oral mucosa help maintain the barrier and protect against infections. ILC3s and intraepithelial ILC1s were initially identified in tonsils and found in human gingivae. Approximately 10–15%
1392:
in both mice and humans, via epidermal Notch1 signalling. The ILC3s secrete IL-17F, which plays a role in the immune, and epithelial cellular responses during wound healing, by recruiting macrophages to the site. The expression of TNF also plays a role in wound healing as it directs localization of
1350:
proliferation, and therefore mucus production in the respiratory tract. These functions contribute to the restoration and maintenance of epithelial integrity. ILC2s provide a defence against helminth infections in the lung, via the production of AhR, IL-9, and IL-13. It is believed that these ILC2s
1191:
are the population of ILCs with the most significant anti-tumorigenic potential, with NK cells possessing the ability to recognise missing MHC Class I on the surface of tumor cells. In this way, they act in a complementary manner with the cytotoxic T cells that recognize and kill tumor cells which
982:
ILCs participate in our immune response to pathogens in all organs, in particular at mucosal surfaces. They are key in the innate immune response due to their ability to rapidly secrete immunoregulatory cytokines, however, they also play a role in the shaping of the adaptive response by interacting
725:
There are two subsets of ILC3s, NCR- and NCR+ ILC3s, with the displayed NCR on mice ILC3s being NKp46, in comparison to NKp44 displayed on human ILC3s. NKp44+ ILC3s are highly enriched in the tonsils and intestines, as an exclusive source of IL-22. Some ILC3s can also express other NK cell markers,
1665:
The ILCs have been studied in mucosal barriers and their interplay with adaptative immunity, thus implicating them with autoimmune diseases. In arthritis characterized by autoantibodies presence, the dysregulated crosstalk between Tfh and B cells has been implicated in generating those antibodies.
1232:
can also be involved in pro or anti-tumorigenic environments. The production of IL-17 can support the growth of tumors and metastasis since it induces blood vessel permeability, however, the upregulation of MHC Class II on their surface can prime CD4+ T cells, having an anti-tumorigenic effect. In
492:
between NK cells and ILC1s. Although both cell types use T-bet for development, NK cells have been found to be present in T-bet deficient hosts, but ILC1s are completely dependent on its presence. Development of NK cells is, however, completely dependent on the presence of the transcription factor
837:
Our understanding of the pathways involved in the development of ILCs has only become clear in the last few years, with our knowledge mainly based on mouse pathways. CLPs have the ability to differentiate into a number of different cell types including T cells, B cells, and ILCs, depending on the
1577:
is frequently observed in response to chronic liver inflammation, and increased proliferation of these ducts is associated with liver cancer. Evidence suggests that the enhanced proliferation is triggered by IL-13, which is produced by IL-33 induced production of ILC2 cells. ILC2s have also been
1456:
The production of IL-5 by ILC2s in the lung leads to eosinophil recruitment, and other cell populations are known to interact and shape the presence of lung ILC2s in airway inflammation in asthmatic patients. In addition, they also promote proliferation of B cells. It is believed the increase in
1068:
ILCs facilitate maintenance of barrier integrity in the intestine, protecting from various bacteria and viral infections. ILC3s are the most abundant subset present in both the adult and foetal intestine. The distribution of ILCs in the intestine changes during development, and they are unevenly
877:
including T and B cells. CILPs can then differentiate into NK cell precursors (NKP), or the more recently described common helper innate lymphoid progenitors (CHILPs). CHILPs can then differentiate into lymphoid tissue inducer progenitors (LTiPs), and innate lymphoid cell precursors (ILCPs). The
1687:
system, several studies suggest their development and phenotypic maintenance is much more complex, with a high level of plasticity between the subsets. Studies have confirmed the ability of some ILC subsets to convert into a different subset in the presence of specific cytokines. This is also a
1611:, contributing to the development of obesity. Upon dysregulation of homeostasis in the adipose tissue, the decreased responses of ILC2s are a characteristic of obesity, as this interrupts their crucial role in energy homeostasis, resulting in reduced energy expenditure, and increased adiposity. 516:
has been shown to distinguish NK cells from ILC1s. The relationship between the ILC1 and NK cell lineages still remains fuzzy due to a lack of these characteristic markers present on some NK/ILC1 cells in certain tissues, or after certain infection/inflammation events. This supports the tissue
1473:
NK cells express many cell-surface receptors that can be activating, inhibitory, adhesion, cytokine, or chemotactic. The integration of information collected through these numerous inputs allows NK cells to maintain self-tolerance and recognize self-cell stress signals. If the nuanced, dynamic
1464:
How other ILCs impact asthma is less clear, however studies show correlation between the number of IL-17 producing ILC3s, and the severity of the disease. It has been shown in mice that NK cells and ILC1s inhibit ILC2 expansion due to the production of IFN-γ, and therefore may help control the
1599:
triggers inflammation, acting on innate immune cells, including ILC1s, therefore playing an important role in the activation of an inflammatory state in the liver. Therefore, inflammation associated with obesity can influence the progression of liver disease, due to the development of insulin
1560:
due to chronic inflammation, when the ILC3s acquire the ILC1 pro-inflammatory phenotype during chronic inflammation. Since ILCs accumulate in the intestine of IBD patients, it is believed they may have a pro-tumorigenic role. Supporting this, studies show an increase in the amount of effector
1719:
The signaling induced by the cytokines governs the plasticity between ILC3 and ILC1, inducing the expression of T-bet. In patients with Crohn’s disease, the increase of ILC1 at the expense of ILC3 possibly by the production of IL-2 from T regulatory cell, leading to a pathogenic state and
750:
LTi cells are considered a separate lineage due to their unique developmental pathway, however, they are often considered to be part of the ILC3 group due to their many similar characteristics. Like ILC3s, LTi cells are dependent on RORγt. They are involved in the formation of secondary
142:(inbuilt behavioural changes following a daily cycle). Once matured, the ILCs release cytokines. The classification of ILCs is therefore based on the differences in the transcription factor and cytokine profiles associated with the development and function of the different ILC subtypes. 1424:
cells, and a disrupted uptake of lipids in the intestine. On the other hand, the deletion of Nr1d1, a protein implicated in regulating circadian metabolic responses, resulted in the reduction of NCR+ ILC3 and the increase of IL-17 production, while did not affect the LTi-like ILC3.
1711:
has been shown in vitro, and in vivo. When ILC3s are cultured with IL-2 and IL-15, it causes the up-regulation of T-bet, and the IL-12 receptor (IL-12R) β2, allowing conversion of ILC3s to ILC1s. In addition, studies suggest IL-23 can promote the conversion of ILC1s into ILC3s.
1318:
infection. Retinoic acid also enhances the expression of gut- homing markers on ILC1s, and ILC3s. Dietary nutrient availability therefore modifies the ILC immune response to infection and inflammation, highlighting the importance of a balanced and healthy diet.
1225:
produce cytokines that promote an anti-inflammatory immune response e.g. IL-13, IL-4, Amphiregulin, favouring tumor growth. However, in some settings ILC2s can produce IL-5 promoting a cytotoxic response from eosinophils and therefore an anti-tumor response.
1674:
In the case of ILC3 in multiple sclerosis, these cells have been implicated with tertiary lymphoid aggregates in the brain of patients with progressive disease. In addition, the increase of LTi-like ILC3 correlated with the autoantibodies in the brain fluid.
1069:
distributed throughout the segments of the gastro-intestinal tract. This distribution to different niches within the intestine is mediated through distinct signalling cascades. In humans, approximately 70% of the intestinal ILCs are NCR+, and 15% are NCR-.
1131:, induce IL-22 production by ILC3s. Dendritic cells can also produce IL-23 during pathogen induced stress, also activating ILC3s allowing production of IL-22. One of the mechanisms by which IL-22 regulates microbiota present in the gut is through the 965:
NK cell precursors, and ILC3 precursors have been found in the human tonsil, and foetal ILCPs present in the mouse intestine, accumulating in the Peyer’s Patches. Retinoic acid, produced by many cell types, such as nerve cells, dendritic cells, and
1715:
There is increasing evidence indicating that ILC2s also have a certain degree of plasticity, with studies confirming their ability to convert into ILC1s and ILC3s upon exposure to specific environmental stimuli such as cytokines, or notch ligands.
1207:
to the site, creating an inflammatory environment. If successful, the recruitment of these cells will kill the tumorigenic cells, however in some cases, IFN-γ and TNF-α can play a role in the induction of immunosuppressive immune cells, such as
558:
ILC2s are tissue resident and involved in the innate response to parasites, such as helminth infection, by helping repair tissue damage. They are abundant in tissues of the skin, lung, liver, and gut. They are characterised by the production of
4523:
Heeren, A. Marijne, et al. "High and interrelated rates of PD-L1+ CD14+ antigen-presenting cells and regulatory T cells mark the microenvironment of metastatic lymph nodes from patients with cervical cancer." Cancer immunology research (2014):
990:
Since the function of ILCs is linked to their specific tissue localization, determination of the signals involved in their localization and migration patterns will be important in the identification of new avenues for treatment of diseases.
717:
and IL-23, or pathogenic signals. IL-22 is the principle cytokine produced by ILC3s and plays a fundamental role in maintaining intestinal homeostasis. However, ILC3s produce a variety of other cytokines, including IL-17, IL-22, IFN- γ, and
1249:
All ILC subsets are present in the liver and regulate the immune response to protect the tissue from viral and bacterial infection. ILC1s are the dominant ILC subset present in the liver. Their production of IFN–γ promotes the survival of
1581:
The availability of specific dietary nutrients can affect ILC immune homeostasis by altering the energy stored in the adipose tissue. Adipose tissue maintains metabolism homeostasis and is now considered a fully immunocompetent organ.
73:
Based on the difference in developmental pathways, phenotype, and signalling molecules produced, in 2013, ILCs were divided into three groups: 1, 2 and 3, however, after further investigation, they are now divided into five groups:
1032:
Lung ILC2s are positioned close to blood vessels, to allow recruitment of eosinophils from the blood. They are also positioned within the airways, where potential pathogens may accumulate. This means they are in close contact with
1695:
The ILCs present in the lungs of patients with COPD, which have the ability to convert into different ILC phenotypes, depending on the microenvironment, which can increase inflammation, contributing to the pathophysiology of the
2924:
Cupedo T, Crellin NK, Papazian N, Rombouts EJ, Weijer K, Grogan JL, et al. (January 2009). "Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells".
1460:
This allergic immune response appears to be independent of T and B cells, with evidence confirming that allergic responses that resembling asthma-like symptoms can be induced in mice that lack T and B cells, using IL-33.
986:
The strategic positioning and deep rooting of ILCs within tissues allow them to maintain homeostasis, and therefore healthy tissue functioning. However, the ILCs also have detrimental roles in different mucosal sites.
1590:
can dysregulate ILC responses via changes in dietary nutrients, having direct effects on the energy stored in the adipose tissue. Obesity is associated with changes of gastrointestinal flora, increased afflux of free
5953:
Bal SM, Bernink JH, Nagasawa M, Groot J, Shikhagaie MM, Golebski K, et al. (June 2016). "IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs".
493:
Eomes, whereas ILC1s can develop independent of its presence. This means, Eomes can generally be used as a marker for NK cells, suggesting that mature NK cells are Tbet + Eomes +, and ILC1 are Tbet + Eomes -.
1156:, and deprivation of vitamin A has been shown to enhance ILC2- mediated resistance to helminth infection in mice. ILC3s therefore form a network of interactions to maintain intestinal homeostasis, between the 983:
with other immune cells. The microenvironment of the tissue they reside in determines and fine- tunes the expression of the diverse ILC profiles, facilitating their interaction in multiple effector functions.
1151:
results in abnormally small numbers of ILC3s, and therefore a reduction of IL-22 production, and higher susceptibility to infection. Conversely, retinoic acid suppresses ILC2 proliferation by down regulating
1017:, for epithelial growth factor receptors, which facilitates differentiation of epithelial cells for tissue repair. This can function to enhance the barrier function of the epithelium and slow pathogen entry. 1474:
regulation of NK cell activation becomes unbalanced in favor of attacking self cells, autoimmune disease pathology. NK cell dysregulation has been implicated in a number of autoimmune disorders including
878:
factors present in the microenvironment determine the progression of CLPs towards specific ILC subtypes, including notch ligands, cytokines, circadian rhythm, and the expression of transcription factors.
5601:
Scordamaglia F, Balsamo M, Scordamaglia A, Moretta A, Mingari MC, Canonica GW, et al. (February 2008). "Perturbations of natural killer cell regulatory functions in respiratory allergic diseases".
3956:
Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, et al. (September 2007). "IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways".
6390: 1595:
from adipose tissue into the liver and increased gut permeability. The close anatomical proximity of the gastrointestinal tract and the liver means transportation of bacterial metabolites through the
1192:
present a foreign antigen on MHC class I. NK cells express a number of cell surface activating NK cell receptors with specificity for stress induced ligands overexpressed on tumor cells. See the
6203:
Gao Y, Souza-Fonseca-Guimaraes F, Bald T, Ng SS, Young A, Ngiow SF, et al. (September 2017). "Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells".
1393:
ILC3s to the damaged skin epidermis. In response to the release of IL-33 by the epidermis, ILC2s secrete high levels amphiregulin, a critical epidermal growth factor, therefore contributing to
1502:
The ILCs present in the nasal polyps of patients with allergic rhinitis, forming a positive feedback loop, promoting inflammation, therefore contributing to the pathophysiology of the disease.
1441:
The ILCs present in the lungs of patients with asthma, and the effector cytokines and cells involved in contributing to the pathophysiology of the disorder, by promoting a Th2 immune response.
1657:. However, more recent data suggests that ILC3s in fact produce a large number of these cytokines, with an increase in the number of ILC3s in the peripheral blood of patients with psoriasis. 1521:
ILC2s are activated due to presence of TSLP and IL-4, produced by epithelial cells and eosinophils respectively. They then produce IL-4, IL-5, and IL-13, further activating eosinophils, in a
1177:, ILC1s and ILC3s cooperate to combat the infection. ILC2s induce goblet cell differentiation, and mucus production in the intestine to protect from tissue damage upon parasitic infection. 821:, the autoimmune regulatory gene, by allowing development of embryonic thymic epithelial cells. They do this via lymphotoxin α4β7 and RANK-L signalling. LTi cells also allow the survival of 1742:
Determining the extent of ILC plasticity during disease could be useful to allow us to prevent or enhance their conversion into other subsets that may be contributing to the pathogenicity.
1525:
loop, promoting inflammation. Disrupting this loop could be a potential therapy for rhinitis. NK cells appear to play a beneficial role, with fewer present in those with allergic rhinitis.
1326:, via the production of IL-5, IL-4 and IL-13. This regulates adiposity, insulin resistance, and caloric expenditure. Dysregulation of this causes persistent type 1 inflammation, leading to 1600:
resistance and metabolic dysregulation. ILC1s as a key regulatory of adipose tissue inflammation, are therefore a potential therapeutic target for treating people with liver disease or
970:, favours the differentiation of ILC3s, rather than ILC2s, and it is required for their complete maturation. In addition, AhR, which can be triggered through ligands produced after the 2003:
Klose CS, Kiss EA, Schwierzeck V, Ebert K, Hoyler T, d'Hargues Y, et al. (February 2013). "A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells".
130:
The development of ILCs is initiated in response to the presence of transcription factors that are switched on due to the presence of surrounding microenvironmental factors, such as:
668:. iILC2s, express more KLRG1, and reduced Thy1 and ST2. In addition to these subpopulations, another population, named the ILC210 cell, is characterised by its ability to produce 1623:
than in healthy patients. The ILC2s from the skin of the patients had upregulation of the IL-25, IL-33, TSLP and PGD2 receptors, suggesting their role in the activation of ILC2s.
3864:
Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, et al. (March 2008). "Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens".
1445:
ILC2s have been confirmed to play a pathogenic role during lung inflammation. Epithelial cells in the lung express the cytokines IL-33 and IL-25, or TSLP, in response to various
461:
are up-regulated in tissues after infection or injury, and secrete TGFβ1 in tandem with IFN-γ when stimulated. This drives gut epithelial and extra-cellular matrix remodelling.
1199:
ILC1s influence the tumor microenvironment by the production of the cytokines IFN-γ and TNF-α, which at the beginning of immune response polarize other immune cells, such as
1013:
The infection can lead to tissue damage, due to migration of the helminth. ILC2s have a key role in repairing the tissue damage after infection, by producing ligands such as
3682:
Bernink JH, Peters CP, Munneke M, te Velde AA, Meijer SL, Weijer K, et al. (March 2013). "Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues".
954:
in adults, as this is where CLPs, NKPs, and CHILPs have been found. The cells then exit and circulate in the blood until they reach their designated tissues, coded for by
1384:
ILC3s and ILC2s are recruited to the wounded dermis in both mice and humans in order to aid in the healing process, by recruiting effector cells to the damaged epidermis.
962:. However, it has also been shown that the maturation of the ILCs can take place outside the primary lymphoid tissues, similar to the maturation of naïve T helper cells. 42:(immune associated), and non- lymphoid tissues, and rarely in the blood. They are particularly abundant at mucosal surfaces, playing a key role in mucosal immunity and 686:
ILC3s are involved in the innate immune response to extracellular bacteria and fungi. They play a key role in homeostasis of the intestinal bacteria and in regulating
6523: 1646:
The ILCs present in the epidermis of patients with atopic dermatitis, and the effector cells and cytokines involved in causing the pathophysiology of the disease.
1076:
ILCs and some of their key roles in the intestinal mucosa, allowing maintenance of intestinal homeostasis, via their associated cytokines and effector cells.
1573:
Hepatic ILC1s contribute to pathogenesis of chronic hepatitis B due to the production of IFN-γ, and TNF-α. Disturbance of the epithelium lining the hepatic
1006:
IL-13 also activates T cells, inducing further physiological responses to expel the parasite. T cells stimulate goblet cell mucus secretion, contraction of
1638:
The ILCs present in the epidermis of patients with psoriasis, and the effector cytokines and cells involved in causing inflammation/ epidermal thickening.
1171:, which promotes host commensalism with the local microbiota. ILC1s, and NK cells, produce IFN-γ to combat intracellular pathogens. Upon infection of 445:
Due to ILC1s and NK cells having both shared and unshared features, the classification of human ILC1s has been problematic. Both cell types produce
438:
cells. ILC1s, are non- cytotoxic or weakly cytotoxic, tissue resident cells, functioning in the defence against infections with viruses and certain
4536:"T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production" 719: 1024:
The different ILC subtypes and how they are implicated in tissue repair and regeneration after infection with oversized organs such as helminths.
802:
is another good marker for LTi cells in adult mice and humans. They can be either CD4+/-. Like ILC3s, upon activation, LTi cells mostly produce
4838:"Type 1 Innate Lymphoid Cells Protect Mice from Acute Liver Injury via Interferon-γ Secretion for Upregulating Bcl-xL Expression in Hepatocytes" 1537:
The ILCs present in the intestine of patients with IBD, and the effector cytokines and cells contributing to the pathophysiology of the disease.
999:
A fundamental property of type 2 immunity, and therefore ILC2 cells, is to deal with oversized organisms, that cannot be digested, such as the
1065:
in the bone marrow, so can directly home to the intestine, however, retinoic acid is required to allow CCR9 expression on ILC1s, and ILC3s.
512:
on human ILC1s, which is not present on all NK cells. In addition, NKp80, a marker for human NK cells, is not expressed on ILC1s. In mice,
3078:"Developing lymph nodes collect CD4+CD3- LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells" 1759:
focus more on the germline-coding of receptors in the innate immune system versus the rearranged receptors of the adaptive immune system.
5418: 5401: 1096:
in the lumen, allowing it to be exposed to lamina propria phagocytes, leading to T cell priming. Although they can present antigens, via
648:. GATA3 is also required for maintenance of ILC2 function, with GATA3 deprivation inhibiting the development and function of the cells. 521:, although expressed by the majority of ILC1s, is absent from the salivary gland resident ILC1s, which also have the ability to express 1233:
addition, ILC3s have been reported to promote the formation of tertiary lymphoid structures in lung cancer, playing a protective role.
838:
cellular signals present. With the exception of NK cells, all ILCs require IL-7 signalling for survival. The transcriptional repressor
1731:
In certain environments, such as inflammation, chronic disease, or tumor microenvironments, activated NK cells can start to express
4109:
Macpherson AJ, Yilmaz B, Limenitakis JP, Ganal-Vonarburg SC (April 2018). "IgA Function in Relation to the Intestinal Microbiota".
1465:
disease. Further research in human patients is required to determine how the balance between the different subsets impacts asthma.
829:, which signal to CD4+ T cells. This role could be used to prevent autoimmunity and to enhance memory responses after vaccination. 355: 6061:"Interleukin-12 and -23 Control Plasticity of CD127(+) Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria" 5796:"Polarization of ILC2s in peripheral blood might contribute to immunosuppressive microenvironment in patients with gastric cancer" 5637:
Langowski JL, Zhang X, Wu L, Mattson JD, Chen T, Smith K, et al. (July 2006). "IL-23 promotes tumour incidence and growth".
3369:"AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch" 1515: 825:, and therefore memory immune responses, within newly formed lymph nodes. They do this via the TNF superfamily members OX40L and 6405: 5451:"Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity" 5110:"Activation of Type 3 innate lymphoid cells and interleukin 22 secretion in the lungs during Streptococcus pneumoniae infection" 1057:
Intestinal ILCs are exposed to dietary, microbial, and endogenous metabolites. ILC homing to the small intestine is mediated by
5302:"Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation" 931: 4146:"Innate Immune Defenses Mediated by Two ILC Subsets Are Critical for Protection against Acute Clostridium difficile Infection" 1219:
The role of ILC2s and ILC3s in tumor surveillance is dependent on the microenvironment encountered in their resident tissues.
6437: 6295:
Bald T, Wagner M, Gao Y, Koyasu S, Smyth MJ (February 2019). "Hide and seek: Plasticity of innate lymphoid cells in cancer".
1701: 4477:"Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells" 106:, therefore they have been suggested to be the innate counterparts of T cells. The dysregulation of ILCs can lead to immune 2217: 2213:"T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow" 1792:
Spits H, Cupedo T (2012). "Innate lymphoid cells: emerging insights in development, lineage relationships, and function".
6656: 873:
ILCs are derived from common innate lymphoid progenitors (CILPs), which are derived from CLPs, which have the ability to
405: 4428:"Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells" 1490:(IL-23, IL-1B, or IL-6), or their survival factors (IL-7) could be used as an approach to treat inflammatory diseases. 1172: 38:, and the regulation of both innate and adaptive immune cells. ILCs are primarily tissue resident cells, found in both 5000:"IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation" 3821:
Ebbo M, Crinier A, Vély F, Vivier E (November 2017). "Innate lymphoid cells: major players in inflammatory diseases".
1724:
and T-bet, different questions remain that need to be explained to understand the inflammation caused by these cells.
811: 764: 710: 641: 422:
lineages diverge early in their developmental pathways and can be discriminated by their difference in dependence on
90:, and lymphoid tissue inducer (LTi) cells. ILCs are implicated in multiple physiological functions, including tissue 3909:"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells" 890:, to mediate suppression of the lymphoid cell fates generating T and B cells. It does this via reducing activity of 6692: 5402:"Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response" 4585:"Identification of innate IL-5-producing cells and their role in lung eosinophil regulation and antitumor immunity" 846:, yielding an ID2-dependent precursor that can further differentiate with lineage-specific transcription factors. 6339: 1209: 1038: 849:
ILCs are recombination activating gene (RAG)- independent, instead, they rely on cytokine signalling through the
1010:, and they secrete signals recruiting mast cells and eosinophils to the site, stimulating B cell proliferation. 1506:
The frequency of ILC2s has also been found to be elevated in other tissues with allergic symptoms, such as the
430:, and their resident marker expression. NK cells are cytotoxic cells, circulating in the bloodstream, killing 6615: 4378: 783: 731: 602:, which are involved in the distribution of lymphoid cells to specific organ sites. In humans, ILC2s express 59: 5847:"Natural killer cell activity for IFN-gamma production as a supportive diagnostic marker for gastric cancer" 5690:"A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses" 6737: 6707: 6687: 6248:"SMAD4 impedes the conversion of NK cells into ILC1-like cells by curtailing non-canonical TGF-β signaling" 4949:"Adipose Natural Killer Cells Regulate Adipose Tissue Macrophages to Promote Insulin Resistance in Obesity" 2328:"Natural Killer Cells and Type 1 Innate Lymphoid Cells Are New Actors in Non-alcoholic Fatty Liver Disease" 1479: 681: 580: 482: 6246:
Cortez VS, Ulland TK, Cervantes-Barragan L, Bando JK, Robinette ML, Wang Q, et al. (September 2017).
5251:"Immunoregulatory Sensory Circuits in Group 3 Innate Lymphoid Cell (ILC3) Function and Tissue Homeostasis" 3235:"Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages" 481:
produced by both cell types also aid in the eradication of infection. ILC1s and NK cells can also produce
6725: 6720: 6560: 1794: 3274:
Xu W, Domingues RG, Fonseca-Pereira D, Ferreira M, Ribeiro H, Lopez-Lastra S, et al. (March 2015).
1365:
ILC3s are also implicated in lung infections, through the secretion of IL-17, and IL-22, for example in
1300:
ILCs play an important role in maintaining dietary stress, and metabolic homeostasis. The production of
1153: 942:. This provides evidence for the tissue signals playing a key role in fate decisions into ILC lineages. 910:
Each stage of differentiation is dependent on expression of different transcription factors, including:
791: 518: 509: 4583:
Ikutani M, Yanagibashi T, Ogasawara M, Tsuneyama K, Yamamoto S, Hattori Y, et al. (January 2012).
1578:
shown to enhance the progression of liver fibrosis, in turn promoting the development of liver cancer.
1546: 603: 508:
in both humans and mice. They also have differences in phenotypic markers, including the expression of
31: 6410: 5999:"Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity" 6430: 6395: 1305: 935: 895: 6059:
Bernink JH, Krabbendam L, Germar K, de Jong E, Gronke K, Kofoed-Nielsen M, et al. (July 2015).
3907:
Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, et al. (September 2006).
3580:
Dahlgren MW, Jones SW, Cautivo KM, Dubinin A, Ortiz-Carpena JF, Farhat S, et al. (March 2019).
2684:"The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells" 1683:
Our classification of ILCs into subsets provides a simplified framework, however, despite the above
4204:
Wagner M, Moro K, Koyasu S (May 2017). "Plastic Heterogeneity of Innate Lymphoid Cells in Cancer".
1957:
Walker JA, Barlow JL, McKenzie AN (February 2013). "Innate lymphoid cells--how did we miss them?".
1483: 1366: 1185:
Different groups of innate lymphoid cells have ability to influence tumorigenesis in several ways.
3320:"Identification and distribution of developing innate lymphoid cells in the fetal mouse intestine" 34:(CLPs). In response to pathogenic tissue damage, ILCs contribute to immunity via the secretion of 6764: 5501:
Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, et al. (January 2011).
5300:
Halim TY, Steer CA, Mathä L, Gold MJ, Martinez-Gonzalez I, McNagny KM, et al. (March 2014).
4998:
Turner JE, Morrison PJ, Wilhelm C, Wilson M, Ahlfors H, Renauld JC, et al. (December 2013).
4890:
Brestoff JR, Kim BS, Saenz SA, Stine RR, Monticelli LA, Sonnenberg GF, et al. (March 2015).
4728:"NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures" 4726:
Carrega P, Loiacono F, Di Carlo E, Scaramuccia A, Mora M, Conte R, et al. (September 2015).
4000:
Ibiza S, García-Cassani B, Ribeiro H, Carvalho T, Almeida L, Marques R, et al. (July 2016).
2527:
Kim BS, Siracusa MC, Saenz SA, Noti M, Monticelli LA, Sonnenberg GF, et al. (January 2013).
2144:
Jowett GM, Norman MD, Yu TT, Rosell Arévalo P, Hoogland D, Lust ST, et al. (February 2021).
1907: 1200: 611: 135: 5739:"Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth" 2723:
Juelke K, Romagnani C (February 2016). "Differentiation of human innate lymphoid cells (ILCs)".
1212:, and therefore anti-inflammatory cytokines, allowing an immune environment the tumor cells can 1135:
patterns of epithelial cells. IL-22, and lymphotoxin expression by ILC3s controls expression of
6800: 6607: 5737:
Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D, et al. (November 2012).
1755: 1359: 1310: 1259: 1116: 955: 4782:"Type 2 Innate Lymphoid Cells in Liver and Gut: From Current Knowledge to Future Perspectives" 2682:
Mjösberg J, Bernink J, Golebski K, Karrich JJ, Peters CP, Blom B, et al. (October 2012).
2578:"Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells" 2377:
Weizman OE, Adams NM, Schuster IS, Krishna C, Pritykin Y, Lau C, et al. (November 2017).
1829:
Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. (February 2013).
6646: 6623: 6599: 5200:
Vivier E, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. (August 2018).
5051:"S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense" 3367:
Lee JS, Cella M, McDonald KG, Garlanda C, Kennedy GD, Nukaya M, et al. (November 2011).
2101:
Vivier E, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. (August 2018).
1592: 1372:. Further studies are required to decipher the role of ILCs in human respiratory infections. 1314: 869:
Schematic diagram of the development of ILCs, mainly based on mouse differentiation pathways.
485:, further contributing to the inflammatory response, depending on their molecule expression. 218: 46:. Characteristics allowing their differentiation from other immune cells include the regular 5449:
Kim HY, Lee HJ, Chang YJ, Pichavant M, Shore SA, Fitzgerald KA, et al. (January 2014).
4287:"Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells" 4285:
Dadi S, Chhangawala S, Whitlock BM, Franklin RA, Luo CT, Oh SA, et al. (January 2016).
4060:
Goto Y, Obata T, Kunisawa J, Sato S, Ivanov II, Lamichhane A, et al. (September 2014).
2529:"TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation" 6795: 6487: 6423: 6010: 5750: 5646: 5514: 5062: 4903: 4739: 4013: 3536: 2771: 2638: 2159: 2014: 1768: 1751: 1608: 1213: 1124: 818: 638: 423: 286: 27: 4122: 2971:
Takatori H, Kanno Y, Watford WT, Tato CM, Weiss G, Ivanov II, et al. (January 2009).
1807: 1254:. The production of IFN-γ by ILC1s is dependent on the expression of the NK cell receptor 465:
co-stimulation also significantly increases IFN-γ levels. The release of IFN-γ stimulates
8: 6679: 6518: 4892:"Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity" 4426:
Fuchs A, Vermi W, Lee JS, Lonardi S, Gilfillan S, Newberry RD, et al. (April 2013).
4002:"Glial-cell-derived neuroregulators control type 3 innate lymphoid cells and gut defence" 2758:
Buonocore S, Ahern PP, Uhlig HH, Ivanov II, Littman DR, Maloy KJ, Powrie F (April 2010).
1550: 1193: 1072: 1058: 1034: 1029:
the helminth has developed in the intestine, and migrated to the lung through the blood.
478: 419: 75: 6400: 6102:"Cutting Edge: Notch Signaling Promotes the Plasticity of Group-2 Innate Lymphoid Cells" 6014: 5754: 5650: 5518: 5066: 4907: 4743: 4017: 3540: 2775: 2642: 2163: 2018: 1642: 1354:
ILC1s and NK cells secrete IFN-γ in response to viral infection in the lungs, including
746:
The different phenotypic markers present on LTi cells present in an embryo and an adult.
6651: 6638: 6370: 6320: 6272: 6247: 6228: 6185: 6128: 6101: 6033: 5998: 5979: 5925: 5900: 5873: 5846: 5822: 5795: 5771: 5738: 5714: 5689: 5670: 5583: 5535: 5502: 5475: 5450: 5431: 5377: 5352: 5328: 5301: 5277: 5250: 5231: 5177: 5150: 5108:
Van Maele L, Carnoy C, Cayet D, Ivanov S, Porte R, Deruy E, et al. (August 2014).
5085: 5050: 5026: 4999: 4975: 4948: 4924: 4891: 4864: 4837: 4808: 4781: 4703: 4676: 4560: 4535: 4501: 4476: 4452: 4427: 4408: 4359: 4311: 4286: 4267: 4172: 4145: 4086: 4061: 4034: 4001: 3982: 3938: 3889: 3846: 3753: 3726: 3707: 3659: 3632: 3608: 3581: 3557: 3524: 3495: 3468: 3444: 3417: 3393: 3368: 3344: 3319: 3207: 3180: 3143: 3118: 2999: 2972: 2950: 2901: 2874: 2841: 2816: 2792: 2759: 2659: 2626: 2625:
Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, Langford TK, et al. (April 2010).
2602: 2577: 2553: 2528: 2504: 2477: 2405: 2378: 2354: 2327: 2292: 2265: 2241: 2212: 2211:
Daussy C, Faure F, Mayol K, Viel S, Gasteiger G, Charrier E, et al. (March 2014).
2193: 2180: 2145: 2038: 1982: 1931: 1902: 1860: 1654: 1601: 1561:
cytokines IL-23, IL-17, and IL-22, in the tumor microenvironment of intestinal cancer.
1475: 1136: 1128: 950:
Studies suggest primary site of ILC development is in the liver in the foetus, and the
850: 714: 599: 119: 3094: 3077: 2430:"Cutting edge: Salivary gland NK cells develop independently of Nfil3 in steady-state" 1351:
originate in the intestine and migrate into the lung to fight the helminth infection.
974:
food, is required for the maintenance of function and expression of intestinal ILC3s.
6702: 6583: 6502: 6482: 6362: 6324: 6312: 6277: 6220: 6189: 6177: 6133: 6082: 6038: 5971: 5930: 5878: 5827: 5776: 5719: 5688:
Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, et al. (September 2009).
5662: 5619: 5575: 5540: 5480: 5423: 5382: 5333: 5282: 5223: 5182: 5131: 5090: 5031: 4980: 4929: 4869: 4813: 4757: 4708: 4657: 4624:
Wagner M, Ealey KN, Tetsu H, Kiniwa T, Motomura Y, Moro K, Koyasu S (February 2020).
4606: 4565: 4506: 4457: 4400: 4383: 4363: 4351: 4316: 4271: 4259: 4221: 4177: 4144:
Abt MC, Lewis BB, Caballero S, Xiong H, Carter RA, Sušac B, et al. (July 2015).
4126: 4091: 4039: 3974: 3930: 3881: 3838: 3758: 3699: 3664: 3613: 3562: 3500: 3449: 3398: 3349: 3297: 3256: 3212: 3148: 3099: 3058: 3004: 2942: 2906: 2846: 2797: 2740: 2705: 2664: 2607: 2558: 2509: 2451: 2410: 2359: 2297: 2246: 2197: 2185: 2126: 2030: 1974: 1936: 1852: 1811: 1620: 1557: 1522: 1204: 6374: 6100:
Zhang K, Xu X, Pasha MA, Siebel CW, Costello A, Haczku A, et al. (March 2017).
5587: 5435: 5235: 4412: 3986: 3893: 2954: 1986: 6575: 6551: 6354: 6304: 6267: 6259: 6212: 6167: 6123: 6113: 6072: 6028: 6018: 5963: 5920: 5912: 5868: 5858: 5817: 5807: 5766: 5758: 5709: 5701: 5674: 5654: 5611: 5567: 5558:
Baxter AG, Smyth MJ (February 2002). "The role of NK cells in autoimmune disease".
5530: 5522: 5470: 5462: 5413: 5372: 5364: 5323: 5313: 5272: 5262: 5213: 5172: 5162: 5121: 5080: 5070: 5021: 5011: 4970: 4960: 4919: 4911: 4859: 4849: 4803: 4793: 4747: 4698: 4688: 4647: 4637: 4596: 4555: 4547: 4496: 4488: 4447: 4439: 4392: 4343: 4306: 4298: 4251: 4213: 4167: 4157: 4118: 4081: 4073: 4029: 4021: 3966: 3942: 3920: 3873: 3850: 3830: 3748: 3738: 3711: 3691: 3654: 3644: 3603: 3593: 3552: 3544: 3490: 3480: 3439: 3429: 3388: 3380: 3339: 3331: 3287: 3276:"NFIL3 orchestrates the emergence of common helper innate lymphoid cell precursors" 3246: 3233:
Klose CS, Flach M, Möhle L, Rogell L, Hoyler T, Ebert K, et al. (April 2014).
3202: 3192: 3138: 3130: 3089: 3048: 2994: 2984: 2934: 2896: 2886: 2836: 2828: 2787: 2779: 2732: 2695: 2654: 2646: 2597: 2589: 2548: 2540: 2499: 2489: 2441: 2400: 2390: 2349: 2339: 2287: 2277: 2236: 2226: 2175: 2167: 2150: 2116: 2042: 2022: 2005: 1966: 1926: 1916: 1864: 1842: 1803: 1732: 1628: 1168: 756: 687: 537: 446: 139: 39: 5983: 4947:
Lee BC, Kim MS, Pae M, Yamamoto Y, Eberlé D, Shimada T, et al. (April 2016).
4334:
Cerwenka A, Lanier LL (October 2001). "Natural killer cells, viruses and cancer".
2760:"Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology" 2627:"Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity" 1518:. The concentration of ILC2s positively correlates with severity of the diseases. 1498: 886:
The development of CLPs to CILPs and on to ILCs requires the transcription factor
587:. Due to their cytokine signature, they are considered the innate counterparts of 6567: 6232: 6077: 6060: 5318: 4854: 4642: 4625: 4443: 4217: 3598: 3434: 3292: 3275: 3134: 2700: 2683: 2544: 2494: 1542: 1343: 214: 55: 51: 6154:
Meininger I, Carrasco A, Rao A, Soini T, Kokkinou E, Mjösberg J (October 2020).
4242:
Wagner M, Koyasu S (May 2019). "Cancer Immunoediting by Innate Lymphoid Cells".
2576:
Roediger B, Kyle R, Yip KH, Sumaria N, Guy TV, Kim BS, et al. (June 2013).
2478:"Innate Lymphoid Cells: Diversity, Plasticity, and Unique Functions in Immunity" 6308: 6003:
Proceedings of the National Academy of Sciences of the United States of America
5615: 5218: 5201: 4965: 4551: 4302: 4162: 3925: 3908: 3631:
Sui P, Wiesner DL, Xu J, Zhang Y, Lee J, Van Dyken S, et al. (June 2018).
3251: 3234: 2395: 2121: 2107: 2102: 1437: 1323: 1101: 1042: 1000: 807: 691: 669: 576: 572: 462: 458: 454: 399: 395: 365: 324: 320: 305: 267: 237: 226: 180: 176: 67: 5916: 5863: 5571: 3053: 3036: 2736: 2171: 1020: 759:
by promoting lymphoid tissue development, which they do through the action of
16:
Group of innate immune cells that are derived from common lymphoid progenitors
6789: 6774: 6756: 6594: 6556: 6477: 6172: 6155: 6118: 5901:"Functional interactions between innate lymphoid cells and adaptive immunity" 5845:
Lee J, Park KH, Ryu JH, Bae HJ, Choi A, Lee H, et al. (September 2017).
5368: 5267: 5167: 4693: 4601: 4584: 4492: 4255: 3743: 3582:"Adventitial Stromal Cells Define Group 2 Innate Lymphoid Cell Tissue Niches" 3485: 2891: 2446: 2429: 2344: 2282: 1921: 1331: 1132: 1105: 1007: 874: 843: 822: 771: 634: 588: 568: 564: 541: 474: 368: 347: 271: 263: 259: 95: 6023: 5526: 5419:
10.1002/(SICI)1521-4141(199803)28:03<769::AID-IMMU769>3.0.CO;2-H
5126: 5109: 5075: 5049:
Huang Y, Mao K, Chen X, Sun MA, Kawabe T, Li W, et al. (January 2018).
4836:
Nabekura T, Riggan L, Hildreth AD, O'Sullivan TE, Shibuya A (January 2020).
4677:"The Interplay Between Innate Lymphoid Cells and the Tumor Microenvironment" 4626:"Tumor-Derived Lactic Acid Contributes to the Paucity of Intratumoral ILC2s" 4381:(April 2001). "A fresh look at tumor immunosurveillance and immunotherapy". 4077: 3649: 3197: 3181:"Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology" 2973:"Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22" 2875:"Group 3 ILCs: Peacekeepers or Troublemakers? What's Your Gut Telling You?!" 1708: 1691: 1380: 1241: 6589: 6497: 6492: 6366: 6316: 6281: 6224: 6181: 6137: 6086: 6042: 5975: 5934: 5882: 5831: 5780: 5723: 5666: 5623: 5579: 5544: 5484: 5386: 5337: 5286: 5227: 5186: 5135: 5094: 5035: 4984: 4933: 4873: 4817: 4761: 4712: 4661: 4610: 4569: 4510: 4461: 4404: 4355: 4320: 4263: 4225: 4181: 4130: 4095: 4043: 3978: 3934: 3885: 3842: 3762: 3703: 3668: 3617: 3566: 3504: 3453: 3402: 3353: 3301: 3260: 3216: 3152: 3062: 3008: 2946: 2910: 2850: 2801: 2744: 2709: 2668: 2611: 2562: 2513: 2455: 2414: 2363: 2301: 2250: 2189: 2130: 2034: 1978: 1940: 1856: 1815: 1634: 1627:
and mast cells are also present in these skin lesions, producing IL-4, and
1583: 1286: 1143:
of epithelial cells, providing a nutrient source for the luminal bacteria.
1140: 1097: 1093: 1089: 1085: 1014: 967: 854: 560: 522: 427: 338: 290: 222: 5812: 5427: 4108: 3103: 1528: 6769: 6472: 6467: 5016: 4798: 4652: 4062:"Innate lymphoid cells regulate intestinal epithelial cell glycosylation" 2989: 2266:"T-bet and Eomesodermin in NK Cell Development, Maturation, and Function" 2231: 1596: 1507: 1347: 1278: 1274: 1258:. IL-12-driven IFN-γ production by ILC1s is accelerated by extracellular 951: 799: 760: 699: 584: 391: 331: 91: 43: 5762: 5658: 4915: 4025: 3834: 3548: 2783: 2650: 2026: 865: 6446: 4752: 4727: 3469:"Innate Lymphoid Cells in Helminth Infections-Obligatory or Accessory?" 2379:"ILC1 Confer Early Host Protection at Initial Sites of Viral Infection" 1619:
The frequency of ILC2s is higher in the inflamed skin of patients with
1355: 1301: 1251: 1164: 1157: 1120: 971: 779: 752: 694:
of the intestine, and the tonsils, however, they are also found in the
466: 99: 47: 5600: 713:
for their development and function. They express RORγt in response to
496:
ILC1s and NK cells have some phenotypic markers in common, including:
6742: 6697: 6545: 4347: 2817:"The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing" 1650: 1574: 1511: 1245:
The different ILC subtypes and how they are implicated in metabolism.
1148: 959: 595: 470: 205: 198: 63: 6358: 6263: 6216: 5967: 5705: 5466: 4835: 4582: 3695: 3384: 3335: 2938: 2832: 2593: 1970: 1847: 1830: 1533: 1160:, intestinal epithelium, neuro-glial cells, and other immune cells. 6511: 6462: 6340:"Shades of grey--the blurring view of innate and adaptive immunity" 6245: 3970: 3877: 1624: 1587: 1549:
due to their increased abundance in the intestine of patients with
1446: 1282: 1112:
regulate IL-22 production and allow differentiation of Th17 cells.
881: 533: 529: 439: 208: 131: 35: 5503:"Innate or adaptive immunity? The example of natural killer cells" 4725: 4396: 3999: 3633:"Pulmonary neuroendocrine cells amplify allergic asthma responses" 3273: 544:, due to the sole production of IFN-γ without cytotoxic activity. 6730: 5794:
Bie Q, Zhang P, Su Z, Zheng D, Ying X, Wu Y, et al. (2014).
1773: 1327: 703: 513: 449:
as their principle cytokine and require the transcription factor
111: 6202: 2428:
Cortez VS, Fuchs A, Cella M, Gilfillan S, Colonna M (May 2014).
1196:
page for further information on NK cells in tumor surveillance.
1119:
to maintain intestinal homeostasis, as in response to bacteria,
1041:. Other studies also confirm the regulation of ILC function via 742: 6533: 6454: 4284: 1739:, common ILC1 markers, strengthening their plastic properties. 1541:
Research suggests IL-17 producing NCR- ILC3s contribute to the
1450: 1389: 1267: 927: 695: 661: 453:
to do so. Both cells can also produce IFN-γ when the cytokines
351: 328: 168: 115: 103: 102:, repair, and regeneration. Many of their roles are similar to 6415: 6196: 6058: 2681: 6396:
Innate lymphoid cells: major players in inflammatory diseases
2923: 1736: 1294: 1290: 1263: 1255: 1109: 1081: 923: 915: 911: 899: 891: 826: 803: 787: 665: 645: 627: 619: 615: 607: 497: 450: 435: 431: 375: 361: 312: 301: 282: 251: 241: 183: 5736: 5500: 5199: 3681: 3178: 2143: 2100: 1831:"Innate lymphoid cells--a proposal for uniform nomenclature" 1388:
Evidence shows ILC3s and ILC2s are recruited to the wounded
875:
differentiate into a number of different lymphoid cell types
4997: 3579: 2376: 1828: 1394: 1062: 919: 795: 775: 727: 657: 623: 553: 505: 501: 383: 275: 244: 87: 83: 5107: 3906: 1273:
NK cells play a role in the immune response against viral
6153: 3179:
Eberl G, Colonna M, Di Santo JP, McKenzie AN (May 2015).
2757: 2427: 2146:"ILC1 drive intestinal epithelial and matrix remodelling" 2002: 939: 887: 839: 778:, and the cytokines IL-1B, IL-23, and IL-6. They express 540:, whereas ILC1s are considered the innate counterpart of 387: 190: 6054: 6052: 5687: 5350: 4674: 3366: 2970: 234:
Large extracellular molecules (parasites and allergens)
5952: 5636: 5594: 3993: 3522: 2263: 1529:
Inflammatory bowel disease (IBD), and intestinal cancer
994: 4668: 4623: 4474: 4143: 3863: 2575: 737: 6049: 5894: 5892: 5351:
Oboki K, Nakae S, Matsumoto K, Saito H (April 2011).
4889: 4831: 4829: 4827: 4059: 3820: 3727:"Metabolic Control of Innate Lymphoid Cell Migration" 3232: 3075: 2815:
Gaffen SL, Jain R, Garg AV, Cua DJ (September 2014).
2624: 2326:
Luci C, Vieira E, Perchet T, Gual P, Golub R (2019).
2325: 1289:. They eliminate hepatic cells in fibrotic liver via 536:, NK cells are considered the innate counterparts of 6149: 6147: 5448: 5399: 4425: 4102: 3955: 2966: 2964: 2868: 2866: 2864: 2862: 2860: 2526: 2210: 1956: 1556:
Patients with IBD have an increased risk of getting
489: 6294: 6156:"Tissue-Specific Features of Innate Lymphoid Cells" 5730: 5299: 5101: 4719: 4475:Lechner MG, Liebertz DJ, Epstein AL (August 2010). 4376: 3816: 3814: 3812: 3810: 3808: 3806: 3804: 3802: 3800: 3798: 3796: 3794: 3792: 3174: 3172: 3170: 3168: 3166: 3164: 3162: 2716: 2675: 2257: 1896: 1894: 1607:ILC2s have also been identified in human and mouse 172:Intracellular microbes (virus, bacteria, parasite) 50:, absence of rearranged antigen receptors found on 6099: 5898: 5889: 5630: 4991: 4824: 3900: 3790: 3788: 3786: 3784: 3782: 3780: 3778: 3776: 3774: 3772: 3523:Palm NW, Rosenstein RK, Medzhitov R (April 2012). 3317: 3076:Mebius RE, Rennert P, Weissman IL (October 1997). 2751: 2096: 2094: 2092: 2090: 2088: 2086: 2084: 2082: 2080: 2078: 2076: 2074: 2072: 1892: 1890: 1888: 1886: 1884: 1882: 1880: 1878: 1876: 1874: 1322:ILC2s support a type- 2 immune environment in the 1262:, and IFN-γ upregulates the prosurvival molecules 905: 637:for their development, activating the fundamental 6144: 5996: 5948: 5946: 5944: 5248: 4946: 4779: 4775: 4773: 4771: 4237: 4235: 4199: 4197: 4195: 4193: 4191: 3675: 3630: 3573: 3466: 3409: 3318:Bando JK, Liang HE, Locksley RM (February 2015). 3313: 3311: 3228: 3226: 2961: 2917: 2857: 2814: 2321: 2319: 2317: 2315: 2313: 2311: 2070: 2068: 2066: 2064: 2062: 2060: 2058: 2056: 2054: 2052: 62:gene), and phenotypic markers usually present on 6787: 6239: 4203: 4055: 4053: 3159: 2370: 882:Identification of the ILC progenitor cell (ILCP) 709:ILC3s are dependent on the transcription factor 690:. Human adult ILC3s, are primarily found in the 5793: 5048: 3857: 3769: 3267: 2722: 2421: 1998: 1996: 1871: 341:, antimicrobial peptides, epithelium survival) 285:production, alternative macrophage activation, 5990: 5941: 5604:The Journal of Allergy and Clinical Immunology 5293: 4768: 4333: 4232: 4188: 3949: 3624: 3460: 3308: 3223: 3069: 3030: 3028: 3026: 3024: 3022: 3020: 3018: 2808: 2471: 2469: 2467: 2465: 2308: 2204: 2049: 1163:LTi cells are present in Peyer’s patches, and 500:in mice, and NK cell receptors (NCRs) such as 477:effect to eradicate intracellular infections. 6431: 5844: 5400:Kondo H, Ichikawa Y, Imokawa G (March 1998). 4050: 3718: 3415: 2872: 1952: 1950: 1822: 1127:, which through the neuroregulatory receptor 26:) are the most recently discovered family of 5787: 5148: 5042: 4241: 4137: 3518: 3516: 3514: 3360: 1993: 1900: 6093: 5899:Sonnenberg GF, Hepworth MR (October 2019). 5838: 5557: 5496: 5494: 5151:"Innate Lymphoid Cells in Mucosal Immunity" 4786:International Journal of Molecular Sciences 4675:Ducimetière L, Vermeer M, Tugues S (2019). 3110: 3015: 2462: 1903:"Innate Lymphoid Cells in Mucosal Immunity" 1791: 1568: 6438: 6424: 5681: 5442: 4940: 4780:Ochel A, Tiegs G, Neumann K (April 2019). 2264:Simonetta F, Pradier A, Roosnek E (2016). 1947: 1750:Historically, the distinction between the 1037:, which activate ILC2s via the release of 722:, depending on the environmental stimuli. 406:Formation of secondary lymphoid structures 6411:Innate Lymphoid Cells in Mucosal Immunity 6271: 6171: 6127: 6117: 6076: 6032: 6022: 5997:Cella M, Otero K, Colonna M (June 2010). 5924: 5872: 5862: 5821: 5811: 5770: 5713: 5534: 5474: 5417: 5376: 5357:Allergy, Asthma & Immunology Research 5327: 5317: 5276: 5266: 5217: 5176: 5166: 5125: 5084: 5074: 5025: 5015: 4974: 4964: 4923: 4863: 4853: 4807: 4797: 4751: 4702: 4692: 4651: 4641: 4600: 4559: 4500: 4451: 4310: 4171: 4161: 4085: 4033: 3924: 3752: 3742: 3724: 3658: 3648: 3607: 3597: 3556: 3511: 3494: 3484: 3443: 3433: 3392: 3343: 3291: 3250: 3206: 3196: 3142: 3093: 3052: 2998: 2988: 2900: 2890: 2840: 2791: 2699: 2658: 2601: 2552: 2503: 2493: 2445: 2404: 2394: 2353: 2343: 2291: 2281: 2240: 2230: 2179: 2120: 1930: 1920: 1846: 1180: 298:Extracellular microbes (bacteria, fungi) 6331: 5491: 5249:Domingues RG, Hepworth MR (2020-02-06). 3119:"The LTi cell, an immunologic chameleon" 1690: 1641: 1633: 1532: 1497: 1436: 1379: 1337: 1240: 1167:, interacting with B cells facilitating 1071: 1019: 864: 810:, and IL-22. They are mediated by RANK, 741: 374: 311: 250: 189: 6678: 3116: 3034: 2475: 1516:aspirin exacerbated respiratory disease 1236: 1080:ILC3s directly interact with bacterial 1061:, and the receptor CCR9. ILC2s express 945: 653: 517:specific function theory. For example, 6788: 6337: 3467:Löser S, Smith KA, Maizels RM (2019). 1104:, and therefore play a role in T cell 798:, however, no NCRs. The expression of 6419: 4885: 4883: 4123:10.1146/annurev-immunol-042617-053238 1808:10.1146/annurev-immunol-020711-075053 1745: 1728:the mechanism is not understood yet. 1709:ILC3s to convert into ILC1-like cells 1702:chronic obstructive pulmonary disease 1669: 1468: 1418: 851:common cytokine- receptor gamma chain 525:, a fundamental feature of NK cells. 5202:"Innate Lymphoid Cells: 10 Years On" 5004:The Journal of Experimental Medicine 2977:The Journal of Experimental Medicine 2218:The Journal of Experimental Medicine 2103:"Innate Lymphoid Cells: 10 Years On" 1614: 1493: 1092:. ILC3s regulate the containment of 1052: 995:Helminth infection and tissue repair 860: 6657:Mucosal associated invariant T cell 6406:NK and Innate Lymphoid Cell Biology 4533: 3416:Kotas ME, Locksley RM (June 2018). 1684: 842:appears to antagonize B and T cell 817:LTi cells induce the expression of 738:Lymphoid Tissue inducer (LTi) cells 490:dependence on transcription factors 13: 6391:Innate Lymphoid Cells: 10 Years On 5149:Panda SK, Colonna M (2019-05-07). 5114:The Journal of Infectious Diseases 4880: 1700:The ILCs present in patients with 770:Their production is stimulated by 563:, and type 2 cytokines, including 14: 6812: 6384: 1229: 1222: 1188: 125: 79: 6693:Lymphokine-activated killer cell 6445: 6288: 5551: 5393: 5353:"IL-33 and Airway Inflammation" 5344: 5242: 5193: 5142: 4617: 4576: 4527: 4517: 4468: 4419: 4370: 4327: 4278: 3037:"Lymphoid tissue inducer cells" 2618: 2569: 2520: 1039:calcitonin gene-related peptide 906:Transcription factor dependence 675: 547: 413: 5800:Journal of Immunology Research 5406:European Journal of Immunology 2533:Science Translational Medicine 2137: 1785: 1400: 1375: 1309:bacterial infections, such as 1123:in the lamina propria secrete 832: 107: 1: 3095:10.1016/S1074-7613(00)80371-4 2725:Current Opinion in Immunology 1779: 1678: 922:, GATA3, PLZF, T-bet, Eomes, 346:Mesenchymal organizer cells ( 6738:Type 3 innate lymphoid cells 6726:Type 2 innate lymphoid cells 6721:Type 1 innate lymphoid cells 6708:Uterine natural killer cells 6688:Cytokine-induced killer cell 6078:10.1016/j.immuni.2015.06.019 5319:10.1016/j.immuni.2014.01.011 4855:10.1016/j.immuni.2019.11.004 4643:10.1016/j.celrep.2020.01.103 4444:10.1016/j.immuni.2013.02.010 4218:10.1016/j.trecan.2017.03.008 3599:10.1016/j.immuni.2019.02.002 3435:10.1016/j.immuni.2018.06.002 3418:"Why Innate Lymphoid Cells?" 3293:10.1016/j.celrep.2015.02.057 3135:10.1016/j.immuni.2010.11.016 2873:Pantazi E, Powell N (2019). 2701:10.1016/j.immuni.2012.08.015 2545:10.1126/scitranslmed.3005374 2495:10.1016/j.immuni.2018.05.013 1901:Panda SK, Colonna M (2019). 1660: 1631:, further activating ILC2s. 1480:systemic lupus erythematosus 1427: 682:Type 3 innate lymphoid cells 594:They express characteristic 7: 6338:Lanier LL (February 2013). 4111:Annual Review of Immunology 3117:Strober W (November 2010). 1795:Annual Review of Immunology 1762: 1360:respiratory syncytial virus 977: 32:common lymphoid progenitors 10: 6817: 6347:Nature Reviews. Immunology 6309:10.1016/j.smim.2019.04.001 5905:Nature Reviews. Immunology 5616:10.1016/j.jaci.2007.09.047 5219:10.1016/j.cell.2018.07.017 4966:10.1016/j.cmet.2016.03.002 4552:10.1016/j.cyto.2015.05.010 4336:Nature Reviews. Immunology 4303:10.1016/j.cell.2016.01.002 4163:10.1016/j.chom.2015.06.011 3926:10.1016/j.cell.2006.07.035 3823:Nature Reviews. Immunology 3252:10.1016/j.cell.2014.03.030 2821:Nature Reviews. Immunology 2396:10.1016/j.cell.2017.09.052 2122:10.1016/j.cell.2018.07.017 1959:Nature Reviews. Immunology 1835:Nature Reviews. Immunology 1409: 679: 551: 6755: 6716: 6669: 6637: 6541: 6532: 6453: 5917:10.1038/s41577-019-0194-8 5864:10.18632/oncotarget.19712 5572:10.1080/08916930290005864 3054:10.1016/j.cub.2011.03.022 2737:10.1016/j.coi.2015.11.005 2172:10.1038/s41563-020-0783-8 1510:of patients with chronic 1432: 857:pathway for development. 622:. In mice, ILC2s express 528:Due to the production of 488:There are differences in 6173:10.1016/j.it.2020.08.009 6119:10.4049/jimmunol.1601421 5369:10.4168/aair.2011.3.2.81 5268:10.3389/fimmu.2020.00116 5168:10.3389/fimmu.2019.00861 4694:10.3389/fimmu.2019.02895 4602:10.4049/jimmunol.1101270 4534:Zhu J (September 2015). 4493:10.4049/jimmunol.1000901 4256:10.1016/j.it.2019.03.004 3744:10.3389/fimmu.2019.02010 3525:"Allergic host defences" 3486:10.3389/fimmu.2019.00620 2892:10.3389/fimmu.2019.00676 2447:10.4049/jimmunol.1303469 2345:10.3389/fimmu.2019.01192 2283:10.3389/fimmu.2016.00241 1922:10.3389/fimmu.2019.00861 1569:Liver cancer and obesity 1484:type I diabetes mellitus 1306:AhR transcription factor 1115:ILC3s interact with the 1102:co-stimulatory molecules 600:receptors for chemokines 146:Immune function of ILCs 58:(due to the lack of the 6765:Hematopoietic stem cell 6524:Lymphoplasmacytoid cell 6024:10.1073/pnas.1005641107 5527:10.1126/science.1198687 5255:Frontiers in Immunology 5155:Frontiers in Immunology 5076:10.1126/science.aam5809 4681:Frontiers in Immunology 4150:Cell Host & Microbe 4078:10.1126/science.1254009 3731:Frontiers in Immunology 3650:10.1126/science.aan8546 3473:Frontiers in Immunology 3198:10.1126/science.aaa6566 3035:Withers DR (May 2011). 2879:Frontiers in Immunology 2476:Colonna M (June 2018). 2332:Frontiers in Immunology 2270:Frontiers in Immunology 1908:Frontiers in Immunology 1514:, and in patients with 1304:metabolites causes the 1203:, dendritic cells, and 894:transcription factors ( 6297:Seminars in Immunology 4377:Smyth MJ, Godfrey DI, 1756:adaptive immune system 1697: 1647: 1639: 1538: 1503: 1442: 1385: 1246: 1181:Tumor microenvironment 1117:enteric nervous system 1077: 1025: 870: 747: 656:. nILC2s express more 538:cytotoxic CD8+ T cells 469:and other mononuclear 379: 316: 255: 194: 6671:Innate lymphoid cells 6647:Natural killer T cell 6106:Journal of Immunology 5127:10.1093/infdis/jiu106 4732:Nature Communications 4589:Journal of Immunology 4481:Journal of Immunology 2434:Journal of Immunology 1694: 1645: 1637: 1536: 1501: 1440: 1383: 1338:Respiratory infection 1315:Citrobacter rodentium 1244: 1100:receptors, ILCs lack 1075: 1023: 868: 745: 639:transcription factors 424:transcription factors 378: 315: 254: 219:Macrophage activation 193: 20:Innate lymphoid cells 6160:Trends in Immunology 5017:10.1084/jem.20130071 4799:10.3390/ijms20081896 4244:Trends in Immunology 3725:Willinger T (2019). 2990:10.1084/jem.20072713 2232:10.1084/jem.20131560 1769:Innate immune system 1609:white adipose tissue 1237:Liver and metabolism 1125:neurotrophic factors 1035:neuroendocrine cells 946:Origin and migration 814:, IL-17, and IL-22. 293:, thermoregulation) 287:extracellular matrix 36:signalling molecules 30:cells, derived from 6639:Innate-like T cells 6519:Transitional B cell 6015:2010PNAS..10710961C 5857:(41): 70431–70440. 5813:10.1155/2014/923135 5763:10.1038/nature11465 5755:2012Natur.491..254G 5659:10.1038/nature04808 5651:2006Natur.442..461L 5519:2011Sci...331...44V 5067:2018Sci...359..114H 4916:10.1038/nature14115 4908:2015Natur.519..242B 4744:2015NatCo...6.8280C 4636:(8): 2743–2757.e5. 4026:10.1038/nature18644 4018:2016Natur.535..440I 3835:10.1038/nri.2017.86 3549:10.1038/nature11047 3541:2012Natur.484..465P 2784:10.1038/nature08949 2776:2010Natur.464.1371B 2651:10.1038/nature08900 2643:2010Natur.464.1367N 2164:2021NatMa..20..250J 2027:10.1038/nature11813 2019:2013Natur.494..261K 1194:Natural killer cell 823:memory CD4+ T cells 688:Th17 cell responses 147: 48:lymphoid morphology 4753:10.1038/ncomms9280 3643:(6393): eaan8546. 2389:(4): 795–808.e12. 1746:Innate or adaptive 1698: 1670:Multiple sclerosis 1648: 1640: 1602:metabolic syndrome 1539: 1504: 1476:multiple sclerosis 1469:Autoimmune disease 1443: 1419:Circadian circuits 1386: 1270:, in hepatocytes. 1247: 1205:cytotoxic T cellss 1165:lymphoid follicles 1137:fucosyltransferase 1094:commensal bacteria 1078: 1026: 956:adhesion molecules 871: 763:, a member of the 748: 380: 317: 256: 195: 145: 120:autoimmune disease 6783: 6782: 6751: 6750: 6665: 6664: 6252:Nature Immunology 6205:Nature Immunology 5956:Nature Immunology 5061:(6371): 114–119. 4384:Nature Immunology 4072:(6202): 1254009. 4012:(7612): 440–443. 3959:Nature Immunology 3684:Nature Immunology 3592:(3): 707–722.e6. 3373:Nature Immunology 3324:Nature Immunology 3191:(6237): aaa6566. 2927:Nature Immunology 2637:(7293): 1367–70. 2582:Nature Immunology 1621:atopic dermatitis 1615:Skin inflammation 1558:intestinal cancer 1523:positive feedback 1494:Allergic rhinitis 1281:, limiting liver 1053:Intestinal mucosa 1043:neuronal circuits 861:Early Development 654:helminth parasite 575:, in response to 411: 410: 337:Type 3 immunity ( 281:Type 2 immunity ( 6808: 6703:Adaptive NK cell 6676: 6675: 6539: 6538: 6440: 6433: 6426: 6417: 6416: 6379: 6378: 6344: 6335: 6329: 6328: 6292: 6286: 6285: 6275: 6243: 6237: 6236: 6211:(9): 1004–1015. 6200: 6194: 6193: 6175: 6151: 6142: 6141: 6131: 6121: 6112:(5): 1798–1803. 6097: 6091: 6090: 6080: 6056: 6047: 6046: 6036: 6026: 5994: 5988: 5987: 5950: 5939: 5938: 5928: 5896: 5887: 5886: 5876: 5866: 5842: 5836: 5835: 5825: 5815: 5791: 5785: 5784: 5774: 5734: 5728: 5727: 5717: 5685: 5679: 5678: 5634: 5628: 5627: 5598: 5592: 5591: 5555: 5549: 5548: 5538: 5498: 5489: 5488: 5478: 5446: 5440: 5439: 5421: 5397: 5391: 5390: 5380: 5348: 5342: 5341: 5331: 5321: 5297: 5291: 5290: 5280: 5270: 5246: 5240: 5239: 5221: 5212:(5): 1054–1066. 5197: 5191: 5190: 5180: 5170: 5146: 5140: 5139: 5129: 5105: 5099: 5098: 5088: 5078: 5046: 5040: 5039: 5029: 5019: 4995: 4989: 4988: 4978: 4968: 4944: 4938: 4937: 4927: 4887: 4878: 4877: 4867: 4857: 4848:(1): 96–108.e9. 4833: 4822: 4821: 4811: 4801: 4777: 4766: 4765: 4755: 4723: 4717: 4716: 4706: 4696: 4672: 4666: 4665: 4655: 4645: 4621: 4615: 4614: 4604: 4580: 4574: 4573: 4563: 4531: 4525: 4521: 4515: 4514: 4504: 4472: 4466: 4465: 4455: 4423: 4417: 4416: 4374: 4368: 4367: 4348:10.1038/35095564 4331: 4325: 4324: 4314: 4282: 4276: 4275: 4239: 4230: 4229: 4206:Trends in Cancer 4201: 4186: 4185: 4175: 4165: 4141: 4135: 4134: 4106: 4100: 4099: 4089: 4057: 4048: 4047: 4037: 3997: 3991: 3990: 3953: 3947: 3946: 3928: 3904: 3898: 3897: 3861: 3855: 3854: 3818: 3767: 3766: 3756: 3746: 3722: 3716: 3715: 3679: 3673: 3672: 3662: 3652: 3628: 3622: 3621: 3611: 3601: 3577: 3571: 3570: 3560: 3535:(7395): 465–72. 3520: 3509: 3508: 3498: 3488: 3464: 3458: 3457: 3447: 3437: 3428:(6): 1081–1090. 3413: 3407: 3406: 3396: 3364: 3358: 3357: 3347: 3315: 3306: 3305: 3295: 3271: 3265: 3264: 3254: 3230: 3221: 3220: 3210: 3200: 3176: 3157: 3156: 3146: 3114: 3108: 3107: 3097: 3073: 3067: 3066: 3056: 3032: 3013: 3012: 3002: 2992: 2968: 2959: 2958: 2921: 2915: 2914: 2904: 2894: 2870: 2855: 2854: 2844: 2812: 2806: 2805: 2795: 2770:(7293): 1371–5. 2755: 2749: 2748: 2720: 2714: 2713: 2703: 2679: 2673: 2672: 2662: 2622: 2616: 2615: 2605: 2573: 2567: 2566: 2556: 2539:(170): 170ra16. 2524: 2518: 2517: 2507: 2497: 2488:(6): 1104–1117. 2473: 2460: 2459: 2449: 2425: 2419: 2418: 2408: 2398: 2374: 2368: 2367: 2357: 2347: 2323: 2306: 2305: 2295: 2285: 2261: 2255: 2254: 2244: 2234: 2208: 2202: 2201: 2183: 2151:Nature Materials 2141: 2135: 2134: 2124: 2115:(5): 1054–1066. 2098: 2047: 2046: 2000: 1991: 1990: 1954: 1945: 1944: 1934: 1924: 1898: 1869: 1868: 1850: 1826: 1820: 1819: 1789: 1311:gastrointestinal 1139:2, which allows 289:/tissue repair, 202: 163:Immune Function 148: 144: 140:circadian rhythm 6816: 6815: 6811: 6810: 6809: 6807: 6806: 6805: 6786: 6785: 6784: 6779: 6747: 6712: 6661: 6633: 6627: 6619: 6611: 6603: 6579: 6571: 6564: 6528: 6506: 6449: 6444: 6387: 6382: 6359:10.1038/nri3389 6342: 6336: 6332: 6293: 6289: 6264:10.1038/ni.3809 6258:(9): 995–1003. 6244: 6240: 6217:10.1038/ni.3800 6201: 6197: 6166:(10): 902–917. 6152: 6145: 6098: 6094: 6057: 6050: 6009:(24): 10961–6. 5995: 5991: 5968:10.1038/ni.3444 5951: 5942: 5911:(10): 599–613. 5897: 5890: 5843: 5839: 5792: 5788: 5749:(7423): 254–8. 5735: 5731: 5706:10.1038/nm.2015 5694:Nature Medicine 5686: 5682: 5645:(7101): 461–5. 5635: 5631: 5599: 5595: 5556: 5552: 5499: 5492: 5467:10.1038/nm.3423 5455:Nature Medicine 5447: 5443: 5398: 5394: 5349: 5345: 5298: 5294: 5247: 5243: 5198: 5194: 5147: 5143: 5106: 5102: 5047: 5043: 5010:(13): 2951–65. 4996: 4992: 4953:Cell Metabolism 4945: 4941: 4902:(7542): 242–6. 4888: 4881: 4834: 4825: 4778: 4769: 4724: 4720: 4673: 4669: 4622: 4618: 4581: 4577: 4532: 4528: 4522: 4518: 4473: 4469: 4424: 4420: 4375: 4371: 4332: 4328: 4283: 4279: 4240: 4233: 4202: 4189: 4142: 4138: 4107: 4103: 4058: 4051: 3998: 3994: 3954: 3950: 3905: 3901: 3866:Nature Medicine 3862: 3858: 3829:(11): 665–678. 3819: 3770: 3723: 3719: 3696:10.1038/ni.2534 3680: 3676: 3629: 3625: 3578: 3574: 3521: 3512: 3465: 3461: 3414: 3410: 3385:10.1038/ni.2187 3365: 3361: 3336:10.1038/ni.3057 3316: 3309: 3286:(12): 2043–54. 3272: 3268: 3231: 3224: 3177: 3160: 3115: 3111: 3074: 3070: 3041:Current Biology 3033: 3016: 2969: 2962: 2939:10.1038/ni.1668 2922: 2918: 2871: 2858: 2833:10.1038/nri3707 2813: 2809: 2756: 2752: 2721: 2717: 2680: 2676: 2623: 2619: 2594:10.1038/ni.2584 2574: 2570: 2525: 2521: 2474: 2463: 2440:(10): 4487–91. 2426: 2422: 2375: 2371: 2324: 2309: 2262: 2258: 2209: 2205: 2142: 2138: 2099: 2050: 2013:(7436): 261–5. 2001: 1994: 1971:10.1038/nri3349 1955: 1948: 1899: 1872: 1848:10.1038/nri3365 1827: 1823: 1790: 1786: 1782: 1765: 1748: 1707:The ability of 1681: 1672: 1663: 1617: 1571: 1551:Crohn’s disease 1543:pathophysiology 1531: 1496: 1471: 1435: 1430: 1421: 1412: 1403: 1397:wound healing. 1378: 1340: 1239: 1183: 1055: 997: 980: 948: 908: 884: 863: 844:differentiation 835: 765:TNF superfamily 757:Peyer’s patches 740: 684: 678: 596:surface markers 556: 550: 479:Oxygen radicals 473:, to induce an 434:-infected, and 416: 227:oxygen radicals 215:Type 1 immunity 200: 154:Tissue Signals 128: 68:dendritic cells 17: 12: 11: 5: 6814: 6804: 6803: 6798: 6781: 6780: 6778: 6777: 6772: 6767: 6761: 6759: 6753: 6752: 6749: 6748: 6746: 6745: 6740: 6735: 6734: 6733: 6723: 6717: 6714: 6713: 6711: 6710: 6705: 6700: 6695: 6690: 6684: 6682: 6673: 6667: 6666: 6663: 6662: 6660: 6659: 6654: 6649: 6643: 6641: 6635: 6634: 6632: 6631: 6630: 6629: 6625: 6621: 6617: 6613: 6609: 6605: 6601: 6592: 6587: 6577: 6569: 6562: 6554: 6548: 6542: 6536: 6530: 6529: 6527: 6526: 6521: 6516: 6515: 6514: 6504: 6500: 6495: 6490: 6485: 6480: 6475: 6470: 6465: 6459: 6457: 6451: 6450: 6443: 6442: 6435: 6428: 6420: 6414: 6413: 6408: 6403: 6398: 6393: 6386: 6385:External links 6383: 6381: 6380: 6330: 6287: 6238: 6195: 6143: 6092: 6048: 5989: 5940: 5888: 5837: 5786: 5729: 5700:(9): 1016–22. 5680: 5629: 5593: 5550: 5513:(6013): 44–9. 5490: 5441: 5392: 5343: 5292: 5241: 5192: 5141: 5120:(3): 493–503. 5100: 5041: 4990: 4939: 4879: 4823: 4767: 4718: 4667: 4616: 4575: 4526: 4516: 4487:(4): 2273–84. 4467: 4418: 4369: 4326: 4277: 4250:(5): 415–430. 4231: 4212:(5): 326–335. 4187: 4136: 4117:(1): 359–381. 4101: 4049: 3992: 3971:10.1038/ni1488 3948: 3919:(6): 1121–33. 3899: 3878:10.1038/nm1720 3856: 3768: 3717: 3674: 3623: 3572: 3510: 3459: 3408: 3359: 3307: 3266: 3245:(2): 340–356. 3222: 3158: 3109: 3088:(4): 493–504. 3068: 3047:(10): R381-2. 3014: 2960: 2916: 2856: 2827:(9): 585–600. 2807: 2750: 2715: 2674: 2617: 2568: 2519: 2461: 2420: 2369: 2307: 2256: 2203: 2158:(2): 250–259. 2136: 2048: 1992: 1946: 1870: 1821: 1783: 1781: 1778: 1777: 1776: 1771: 1764: 1761: 1747: 1744: 1685:classification 1680: 1677: 1671: 1668: 1662: 1659: 1616: 1613: 1570: 1567: 1530: 1527: 1512:rhinosinusitis 1495: 1492: 1470: 1467: 1434: 1431: 1429: 1426: 1420: 1417: 1411: 1408: 1402: 1399: 1377: 1374: 1342:ILC2s promote 1339: 1336: 1324:adipose tissue 1238: 1235: 1201:M1 macrophages 1182: 1179: 1169:IgA production 1054: 1051: 996: 993: 979: 976: 947: 944: 907: 904: 883: 880: 862: 859: 834: 831: 739: 736: 692:lamina propria 680:Main article: 677: 674: 664:, and reduced 633:ILC2s require 552:Main article: 549: 546: 542:T helper cells 415: 412: 409: 408: 403: 381: 372: 359: 343: 342: 335: 318: 309: 299: 295: 294: 279: 257: 248: 235: 231: 230: 212: 196: 187: 174: 165: 164: 161: 158: 155: 152: 127: 126:Classification 124: 15: 9: 6: 4: 3: 2: 6813: 6802: 6801:Immune system 6799: 6797: 6794: 6793: 6791: 6776: 6775:Prolymphocyte 6773: 6771: 6768: 6766: 6763: 6762: 6760: 6758: 6757:Lymphopoiesis 6754: 6744: 6741: 6739: 6736: 6732: 6729: 6728: 6727: 6724: 6722: 6719: 6718: 6715: 6709: 6706: 6704: 6701: 6699: 6696: 6694: 6691: 6689: 6686: 6685: 6683: 6681: 6677: 6674: 6672: 6668: 6658: 6655: 6653: 6650: 6648: 6645: 6644: 6642: 6640: 6636: 6628: 6622: 6620: 6614: 6612: 6606: 6604: 6598: 6597: 6596: 6595:Memory T cell 6593: 6591: 6588: 6585: 6581: 6573: 6565: 6558: 6555: 6553: 6552:Cytotoxic CD8 6549: 6547: 6544: 6543: 6540: 6537: 6535: 6531: 6525: 6522: 6520: 6517: 6513: 6510: 6509: 6508: 6501: 6499: 6496: 6494: 6491: 6489: 6488:Marginal zone 6486: 6484: 6481: 6479: 6476: 6474: 6471: 6469: 6466: 6464: 6461: 6460: 6458: 6456: 6452: 6448: 6441: 6436: 6434: 6429: 6427: 6422: 6421: 6418: 6412: 6409: 6407: 6404: 6402: 6399: 6397: 6394: 6392: 6389: 6388: 6376: 6372: 6368: 6364: 6360: 6356: 6352: 6348: 6341: 6334: 6326: 6322: 6318: 6314: 6310: 6306: 6302: 6298: 6291: 6283: 6279: 6274: 6269: 6265: 6261: 6257: 6253: 6249: 6242: 6234: 6230: 6226: 6222: 6218: 6214: 6210: 6206: 6199: 6191: 6187: 6183: 6179: 6174: 6169: 6165: 6161: 6157: 6150: 6148: 6139: 6135: 6130: 6125: 6120: 6115: 6111: 6107: 6103: 6096: 6088: 6084: 6079: 6074: 6071:(1): 146–60. 6070: 6066: 6062: 6055: 6053: 6044: 6040: 6035: 6030: 6025: 6020: 6016: 6012: 6008: 6004: 6000: 5993: 5985: 5981: 5977: 5973: 5969: 5965: 5962:(6): 636–45. 5961: 5957: 5949: 5947: 5945: 5936: 5932: 5927: 5922: 5918: 5914: 5910: 5906: 5902: 5895: 5893: 5884: 5880: 5875: 5870: 5865: 5860: 5856: 5852: 5848: 5841: 5833: 5829: 5824: 5819: 5814: 5809: 5805: 5801: 5797: 5790: 5782: 5778: 5773: 5768: 5764: 5760: 5756: 5752: 5748: 5744: 5740: 5733: 5725: 5721: 5716: 5711: 5707: 5703: 5699: 5695: 5691: 5684: 5676: 5672: 5668: 5664: 5660: 5656: 5652: 5648: 5644: 5640: 5633: 5625: 5621: 5617: 5613: 5610:(2): 479–85. 5609: 5605: 5597: 5589: 5585: 5581: 5577: 5573: 5569: 5565: 5561: 5554: 5546: 5542: 5537: 5532: 5528: 5524: 5520: 5516: 5512: 5508: 5504: 5497: 5495: 5486: 5482: 5477: 5472: 5468: 5464: 5460: 5456: 5452: 5445: 5437: 5433: 5429: 5425: 5420: 5415: 5412:(3): 769–79. 5411: 5407: 5403: 5396: 5388: 5384: 5379: 5374: 5370: 5366: 5362: 5358: 5354: 5347: 5339: 5335: 5330: 5325: 5320: 5315: 5312:(3): 425–35. 5311: 5307: 5303: 5296: 5288: 5284: 5279: 5274: 5269: 5264: 5260: 5256: 5252: 5245: 5237: 5233: 5229: 5225: 5220: 5215: 5211: 5207: 5203: 5196: 5188: 5184: 5179: 5174: 5169: 5164: 5160: 5156: 5152: 5145: 5137: 5133: 5128: 5123: 5119: 5115: 5111: 5104: 5096: 5092: 5087: 5082: 5077: 5072: 5068: 5064: 5060: 5056: 5052: 5045: 5037: 5033: 5028: 5023: 5018: 5013: 5009: 5005: 5001: 4994: 4986: 4982: 4977: 4972: 4967: 4962: 4959:(4): 685–98. 4958: 4954: 4950: 4943: 4935: 4931: 4926: 4921: 4917: 4913: 4909: 4905: 4901: 4897: 4893: 4886: 4884: 4875: 4871: 4866: 4861: 4856: 4851: 4847: 4843: 4839: 4832: 4830: 4828: 4819: 4815: 4810: 4805: 4800: 4795: 4791: 4787: 4783: 4776: 4774: 4772: 4763: 4759: 4754: 4749: 4745: 4741: 4737: 4733: 4729: 4722: 4714: 4710: 4705: 4700: 4695: 4690: 4686: 4682: 4678: 4671: 4663: 4659: 4654: 4653:11250/2763785 4649: 4644: 4639: 4635: 4631: 4627: 4620: 4612: 4608: 4603: 4598: 4595:(2): 703–13. 4594: 4590: 4586: 4579: 4571: 4567: 4562: 4557: 4553: 4549: 4545: 4541: 4537: 4530: 4520: 4512: 4508: 4503: 4498: 4494: 4490: 4486: 4482: 4478: 4471: 4463: 4459: 4454: 4449: 4445: 4441: 4438:(4): 769–81. 4437: 4433: 4429: 4422: 4414: 4410: 4406: 4402: 4398: 4397:10.1038/86297 4394: 4390: 4386: 4385: 4380: 4373: 4365: 4361: 4357: 4353: 4349: 4345: 4341: 4337: 4330: 4322: 4318: 4313: 4308: 4304: 4300: 4297:(3): 365–77. 4296: 4292: 4288: 4281: 4273: 4269: 4265: 4261: 4257: 4253: 4249: 4245: 4238: 4236: 4227: 4223: 4219: 4215: 4211: 4207: 4200: 4198: 4196: 4194: 4192: 4183: 4179: 4174: 4169: 4164: 4159: 4155: 4151: 4147: 4140: 4132: 4128: 4124: 4120: 4116: 4112: 4105: 4097: 4093: 4088: 4083: 4079: 4075: 4071: 4067: 4063: 4056: 4054: 4045: 4041: 4036: 4031: 4027: 4023: 4019: 4015: 4011: 4007: 4003: 3996: 3988: 3984: 3980: 3976: 3972: 3968: 3965:(9): 967–74. 3964: 3960: 3952: 3944: 3940: 3936: 3932: 3927: 3922: 3918: 3914: 3910: 3903: 3895: 3891: 3887: 3883: 3879: 3875: 3871: 3867: 3860: 3852: 3848: 3844: 3840: 3836: 3832: 3828: 3824: 3817: 3815: 3813: 3811: 3809: 3807: 3805: 3803: 3801: 3799: 3797: 3795: 3793: 3791: 3789: 3787: 3785: 3783: 3781: 3779: 3777: 3775: 3773: 3764: 3760: 3755: 3750: 3745: 3740: 3736: 3732: 3728: 3721: 3713: 3709: 3705: 3701: 3697: 3693: 3689: 3685: 3678: 3670: 3666: 3661: 3656: 3651: 3646: 3642: 3638: 3634: 3627: 3619: 3615: 3610: 3605: 3600: 3595: 3591: 3587: 3583: 3576: 3568: 3564: 3559: 3554: 3550: 3546: 3542: 3538: 3534: 3530: 3526: 3519: 3517: 3515: 3506: 3502: 3497: 3492: 3487: 3482: 3478: 3474: 3470: 3463: 3455: 3451: 3446: 3441: 3436: 3431: 3427: 3423: 3419: 3412: 3404: 3400: 3395: 3390: 3386: 3382: 3379:(2): 144–51. 3378: 3374: 3370: 3363: 3355: 3351: 3346: 3341: 3337: 3333: 3330:(2): 153–60. 3329: 3325: 3321: 3314: 3312: 3303: 3299: 3294: 3289: 3285: 3281: 3277: 3270: 3262: 3258: 3253: 3248: 3244: 3240: 3236: 3229: 3227: 3218: 3214: 3209: 3204: 3199: 3194: 3190: 3186: 3182: 3175: 3173: 3171: 3169: 3167: 3165: 3163: 3154: 3150: 3145: 3140: 3136: 3132: 3128: 3124: 3120: 3113: 3105: 3101: 3096: 3091: 3087: 3083: 3079: 3072: 3064: 3060: 3055: 3050: 3046: 3042: 3038: 3031: 3029: 3027: 3025: 3023: 3021: 3019: 3010: 3006: 3001: 2996: 2991: 2986: 2982: 2978: 2974: 2967: 2965: 2956: 2952: 2948: 2944: 2940: 2936: 2932: 2928: 2920: 2912: 2908: 2903: 2898: 2893: 2888: 2884: 2880: 2876: 2869: 2867: 2865: 2863: 2861: 2852: 2848: 2843: 2838: 2834: 2830: 2826: 2822: 2818: 2811: 2803: 2799: 2794: 2789: 2785: 2781: 2777: 2773: 2769: 2765: 2761: 2754: 2746: 2742: 2738: 2734: 2730: 2726: 2719: 2711: 2707: 2702: 2697: 2694:(4): 649–59. 2693: 2689: 2685: 2678: 2670: 2666: 2661: 2656: 2652: 2648: 2644: 2640: 2636: 2632: 2628: 2621: 2613: 2609: 2604: 2599: 2595: 2591: 2588:(6): 564–73. 2587: 2583: 2579: 2572: 2564: 2560: 2555: 2550: 2546: 2542: 2538: 2534: 2530: 2523: 2515: 2511: 2506: 2501: 2496: 2491: 2487: 2483: 2479: 2472: 2470: 2468: 2466: 2457: 2453: 2448: 2443: 2439: 2435: 2431: 2424: 2416: 2412: 2407: 2402: 2397: 2392: 2388: 2384: 2380: 2373: 2365: 2361: 2356: 2351: 2346: 2341: 2337: 2333: 2329: 2322: 2320: 2318: 2316: 2314: 2312: 2303: 2299: 2294: 2289: 2284: 2279: 2275: 2271: 2267: 2260: 2252: 2248: 2243: 2238: 2233: 2228: 2225:(3): 563–77. 2224: 2220: 2219: 2214: 2207: 2199: 2195: 2191: 2187: 2182: 2177: 2173: 2169: 2165: 2161: 2157: 2153: 2152: 2147: 2140: 2132: 2128: 2123: 2118: 2114: 2110: 2109: 2104: 2097: 2095: 2093: 2091: 2089: 2087: 2085: 2083: 2081: 2079: 2077: 2075: 2073: 2071: 2069: 2067: 2065: 2063: 2061: 2059: 2057: 2055: 2053: 2044: 2040: 2036: 2032: 2028: 2024: 2020: 2016: 2012: 2008: 2007: 1999: 1997: 1988: 1984: 1980: 1976: 1972: 1968: 1964: 1960: 1953: 1951: 1942: 1938: 1933: 1928: 1923: 1918: 1914: 1910: 1909: 1904: 1897: 1895: 1893: 1891: 1889: 1887: 1885: 1883: 1881: 1879: 1877: 1875: 1866: 1862: 1858: 1854: 1849: 1844: 1840: 1836: 1832: 1825: 1817: 1813: 1809: 1805: 1801: 1797: 1796: 1788: 1784: 1775: 1772: 1770: 1767: 1766: 1760: 1757: 1753: 1743: 1740: 1738: 1734: 1729: 1725: 1723: 1717: 1713: 1710: 1705: 1703: 1693: 1689: 1686: 1676: 1667: 1658: 1656: 1652: 1644: 1636: 1632: 1630: 1626: 1622: 1612: 1610: 1605: 1603: 1598: 1594: 1589: 1585: 1579: 1576: 1566: 1562: 1559: 1554: 1552: 1548: 1544: 1535: 1526: 1524: 1519: 1517: 1513: 1509: 1500: 1491: 1487: 1485: 1481: 1477: 1466: 1462: 1458: 1454: 1452: 1448: 1439: 1425: 1416: 1407: 1398: 1396: 1391: 1382: 1373: 1371: 1369: 1368:S. pneumoniae 1363: 1361: 1357: 1352: 1349: 1345: 1335: 1333: 1332:liver disease 1329: 1325: 1320: 1317: 1316: 1312: 1307: 1303: 1298: 1296: 1292: 1288: 1284: 1280: 1276: 1271: 1269: 1265: 1261: 1257: 1253: 1243: 1234: 1231: 1227: 1224: 1220: 1217: 1215: 1211: 1206: 1202: 1197: 1195: 1190: 1186: 1178: 1176: 1175: 1170: 1166: 1161: 1159: 1155: 1150: 1144: 1142: 1138: 1134: 1133:glycosylation 1130: 1126: 1122: 1118: 1113: 1111: 1107: 1103: 1099: 1095: 1091: 1087: 1083: 1074: 1070: 1066: 1064: 1060: 1059:α4β7 integrin 1050: 1046: 1044: 1040: 1036: 1030: 1022: 1018: 1016: 1011: 1009: 1008:smooth muscle 1004: 1002: 992: 988: 984: 975: 973: 969: 968:stromal cells 963: 961: 957: 953: 943: 941: 937: 934:, RORγt, and 933: 929: 925: 921: 917: 913: 903: 901: 897: 893: 889: 879: 876: 867: 858: 856: 852: 847: 845: 841: 830: 828: 824: 820: 815: 813: 809: 805: 801: 797: 793: 789: 785: 781: 777: 773: 772:retinoic acid 768: 766: 762: 758: 754: 744: 735: 733: 729: 723: 721: 716: 712: 707: 705: 701: 697: 693: 689: 683: 673: 671: 667: 663: 659: 655: 649: 647: 643: 640: 636: 631: 629: 625: 621: 617: 613: 609: 605: 601: 597: 592: 590: 586: 582: 578: 574: 570: 566: 562: 555: 545: 543: 539: 535: 531: 526: 524: 520: 515: 511: 507: 503: 499: 494: 491: 486: 484: 480: 476: 475:antimicrobial 472: 468: 464: 460: 456: 452: 448: 443: 441: 437: 433: 429: 425: 421: 407: 404: 402: 401: 397: 393: 389: 385: 382: 377: 373: 371: 370: 367: 363: 360: 357: 353: 349: 348:retinoic acid 345: 344: 340: 336: 334: 333: 330: 326: 322: 319: 314: 310: 308: 307: 303: 300: 297: 296: 292: 288: 284: 280: 278: 277: 273: 269: 265: 261: 258: 253: 249: 247: 246: 243: 239: 236: 233: 232: 228: 224: 220: 216: 213: 211: 210: 207: 203: 197: 192: 188: 186: 185: 182: 178: 175: 173: 170: 167: 166: 162: 159: 156: 153: 150: 149: 143: 141: 137: 136:notch ligands 133: 123: 121: 117: 113: 109: 105: 101: 97: 96:morphogenesis 93: 89: 85: 81: 77: 71: 69: 65: 61: 57: 53: 49: 45: 41: 37: 33: 29: 28:innate immune 25: 21: 6670: 6350: 6346: 6333: 6300: 6296: 6290: 6255: 6251: 6241: 6208: 6204: 6198: 6163: 6159: 6109: 6105: 6095: 6068: 6064: 6006: 6002: 5992: 5959: 5955: 5908: 5904: 5854: 5850: 5840: 5803: 5799: 5789: 5746: 5742: 5732: 5697: 5693: 5683: 5642: 5638: 5632: 5607: 5603: 5596: 5563: 5560:Autoimmunity 5559: 5553: 5510: 5506: 5461:(1): 54–61. 5458: 5454: 5444: 5409: 5405: 5395: 5360: 5356: 5346: 5309: 5305: 5295: 5258: 5254: 5244: 5209: 5205: 5195: 5158: 5154: 5144: 5117: 5113: 5103: 5058: 5054: 5044: 5007: 5003: 4993: 4956: 4952: 4942: 4899: 4895: 4845: 4841: 4789: 4785: 4735: 4731: 4721: 4684: 4680: 4670: 4633: 4630:Cell Reports 4629: 4619: 4592: 4588: 4578: 4546:(1): 14–24. 4543: 4539: 4529: 4524:canimm-0149. 4519: 4484: 4480: 4470: 4435: 4431: 4421: 4391:(4): 293–9. 4388: 4382: 4372: 4339: 4335: 4329: 4294: 4290: 4280: 4247: 4243: 4209: 4205: 4156:(1): 27–37. 4153: 4149: 4139: 4114: 4110: 4104: 4069: 4065: 4009: 4005: 3995: 3962: 3958: 3951: 3916: 3912: 3902: 3872:(3): 282–9. 3869: 3865: 3859: 3826: 3822: 3734: 3730: 3720: 3690:(3): 221–9. 3687: 3683: 3677: 3640: 3636: 3626: 3589: 3585: 3575: 3532: 3528: 3476: 3472: 3462: 3425: 3421: 3411: 3376: 3372: 3362: 3327: 3323: 3283: 3280:Cell Reports 3279: 3269: 3242: 3238: 3188: 3184: 3129:(5): 650–2. 3126: 3122: 3112: 3085: 3081: 3071: 3044: 3040: 2983:(1): 35–41. 2980: 2976: 2933:(1): 66–74. 2930: 2926: 2919: 2882: 2878: 2824: 2820: 2810: 2767: 2763: 2753: 2728: 2724: 2718: 2691: 2687: 2677: 2634: 2630: 2620: 2585: 2581: 2571: 2536: 2532: 2522: 2485: 2481: 2437: 2433: 2423: 2386: 2382: 2372: 2335: 2331: 2273: 2269: 2259: 2222: 2216: 2206: 2155: 2149: 2139: 2112: 2106: 2010: 2004: 1965:(2): 75–87. 1962: 1958: 1912: 1906: 1841:(2): 145–9. 1838: 1834: 1824: 1799: 1793: 1787: 1749: 1741: 1730: 1726: 1721: 1718: 1714: 1706: 1699: 1682: 1673: 1664: 1649: 1618: 1606: 1584:Malnutrition 1580: 1572: 1563: 1555: 1540: 1520: 1508:nasal polyps 1505: 1488: 1472: 1463: 1459: 1455: 1444: 1422: 1413: 1404: 1387: 1367: 1364: 1353: 1341: 1321: 1313: 1299: 1287:liver cancer 1272: 1248: 1228: 1221: 1218: 1198: 1189:Group 1 ILCs 1187: 1184: 1173: 1162: 1145: 1141:fucosylation 1114: 1098:MHC class II 1090:radiotherapy 1086:chemotherapy 1079: 1067: 1056: 1049:and debris. 1047: 1031: 1027: 1012: 1005: 998: 989: 985: 981: 964: 949: 909: 898:, E2-2, and 885: 872: 848: 836: 816: 769: 749: 724: 708: 706:, and skin. 685: 676:Group 3 ILCs 650: 632: 593: 561:amphiregulin 557: 548:Group 2 ILCs 527: 495: 487: 444: 428:cytotoxicity 417: 414:Group 1 ILCs 394: 364: 339:Phagocytosis 327: 304: 291:vasodilation 274: 240: 223:cytotoxicity 204: 179: 171: 129: 114:, bronchial 72: 23: 19: 18: 6796:Lymphocytes 6770:Lymphoblast 6468:Plasmablast 6447:Lymphocytes 6353:(2): 73–4. 5566:(1): 1–14. 5363:(2): 81–8. 4792:(8): 1896. 4738:(1): 8280. 4342:(1): 41–9. 1597:portal vein 1593:fatty acids 1401:Oral mucosa 1376:Skin repair 1348:goblet cell 1275:hepatitis B 1252:hepatocytes 1174:C. dificile 1121:glial cells 952:bone marrow 855:JAK3 kinase 833:Development 761:lymphotoxin 753:lymph nodes 700:endometrium 467:macrophages 392:Lymphotoxin 332:Lymphotoxin 92:homeostasis 44:homeostasis 6790:Categories 6584:Regulatory 6557:Helper CD4 6483:Follicular 6303:: 101273. 5851:Oncotarget 5806:: 923135. 4379:Trapani JA 1802:: 647–75. 1780:References 1679:Plasticity 1655:γδ T cells 1575:bile ducts 1356:rhinovirus 1344:epithelial 1302:tryptophan 1158:microbiome 972:catabolism 960:chemokines 774:, CXCL13, 726:including 626:, but not 471:phagocytes 160:Mediators 100:metabolism 6743:LTi cells 6698:Null cell 6546:Thymocyte 6401:Why ILCs? 6325:111390262 6190:221636264 4364:205021117 4272:119093972 2731:: 75–85. 2198:221521946 1661:Arthritis 1651:Psoriasis 1625:Basophils 1447:allergens 1428:Pathology 1395:cutaneous 1370:infection 1149:vitamin A 1001:helminths 589:Th2 cells 530:granzymes 418:ILC1 and 206:Granzymes 132:cytokines 108:pathology 6731:Nuocytes 6680:NK cells 6512:B10 cell 6375:27204420 6367:23469373 6317:30979591 6282:28759002 6225:28759001 6182:32917510 6138:28115527 6087:26187413 6065:Immunity 6043:20534450 5976:27111145 5935:31350531 5883:29050291 5832:24741632 5781:23034650 5724:19701202 5667:16688182 5624:18061653 5588:28199633 5580:11908701 5545:21212348 5485:24336249 5436:21654970 5387:21461246 5338:24613091 5306:Immunity 5287:32117267 5236:52079371 5228:30142344 5187:31134050 5136:24577508 5095:29302015 5036:24249111 4985:27050305 4934:25533952 4874:31810881 4842:Immunity 4818:30999584 4762:26395069 4713:31921156 4687:: 2895. 4662:32101749 4611:22174445 4570:26044597 4540:Cytokine 4511:20644162 4462:23453631 4432:Immunity 4413:24779449 4405:11276199 4356:11905813 4321:26806130 4264:30992189 4226:28718410 4182:26159718 4131:29400985 4096:25214634 4044:27409807 3987:21177884 3979:17581537 3935:16990136 3894:15742387 3886:18264109 3843:28804130 3763:31507605 3737:: 2010. 3704:23334791 3669:29599193 3618:30824323 3586:Immunity 3567:22538607 3505:31024526 3454:29924974 3422:Immunity 3403:22101730 3354:25501629 3302:25801035 3261:24725403 3217:25999512 3153:21094460 3123:Immunity 3082:Immunity 3063:21601793 3009:19114665 2955:22864899 2947:19029905 2911:31024537 2851:25145755 2802:20393462 2745:26707651 2710:23063330 2688:Immunity 2669:20200518 2612:23603794 2563:23363980 2514:29924976 2482:Immunity 2456:24740507 2415:29056343 2364:31191550 2338:: 1192. 2302:27379101 2251:24516120 2190:32895507 2131:30142344 2035:23334414 1987:14580303 1979:23292121 1941:31134050 1857:23348417 1816:22224763 1763:See also 1696:disease. 1588:gluttony 1283:fibrosis 978:Function 926:, RORα, 853:and the 534:perforin 440:bacteria 426:, their 209:Perforin 151:Stimuli 110:such as 76:NK cells 40:lymphoid 6534:T cells 6463:B1 cell 6455:B cells 6273:5712491 6129:5321819 6034:2890739 6011:Bibcode 5926:6982279 5874:5642566 5823:3987940 5772:3601659 5751:Bibcode 5715:3034219 5675:4431794 5647:Bibcode 5536:3089969 5515:Bibcode 5507:Science 5476:3912313 5428:9541570 5378:3062800 5329:4210641 5278:7015949 5261:: 116. 5178:6515929 5161:: 861. 5086:6956613 5063:Bibcode 5055:Science 5027:3865473 4976:4833527 4925:4447235 4904:Bibcode 4865:8108607 4809:6514972 4740:Bibcode 4704:6923277 4561:4532589 4502:2923483 4453:3634355 4312:4733424 4173:4537644 4087:4774895 4066:Science 4035:4962913 4014:Bibcode 3943:9034013 3851:2651328 3754:6713999 3712:8614680 3660:6387886 3637:Science 3609:6553479 3558:3596087 3537:Bibcode 3496:6467944 3479:: 620. 3445:6145487 3394:3468413 3345:4297560 3208:5658207 3185:Science 3144:3426921 3104:9354470 3000:2626689 2902:6460375 2885:: 676. 2842:4281037 2793:3796764 2772:Bibcode 2660:2862165 2639:Bibcode 2603:4282745 2554:3637661 2505:6344351 2406:5687850 2355:6546848 2293:4913100 2276:: 241. 2242:3949572 2181:7611574 2160:Bibcode 2043:4390857 2015:Bibcode 1932:6515929 1915:: 861. 1865:2228459 1774:NK Cell 1410:Airways 1362:(RSV). 1328:obesity 1293:and/or 704:decidua 420:NK cell 169:Tumours 112:allergy 104:T cells 64:myeloid 56:B cells 52:T cells 6478:Memory 6473:Plasma 6373:  6365:  6323:  6315:  6280:  6270:  6231:  6223:  6188:  6180:  6136:  6126:  6085:  6041:  6031:  5984:883747 5982:  5974:  5933:  5923:  5881:  5871:  5830:  5820:  5779:  5769:  5743:Nature 5722:  5712:  5673:  5665:  5639:Nature 5622:  5586:  5578:  5543:  5533:  5483:  5473:  5434:  5426:  5385:  5375:  5336:  5326:  5285:  5275:  5234:  5226:  5185:  5175:  5134:  5093:  5083:  5034:  5024:  4983:  4973:  4932:  4922:  4896:Nature 4872:  4862:  4816:  4806:  4760:  4711:  4701:  4660:  4609:  4568:  4558:  4509:  4499:  4460:  4450:  4411:  4403:  4362:  4354:  4319:  4309:  4270:  4262:  4224:  4180:  4170:  4129:  4094:  4084:  4042:  4032:  4006:Nature 3985:  3977:  3941:  3933:  3892:  3884:  3849:  3841:  3761:  3751:  3710:  3702:  3667:  3657:  3616:  3606:  3565:  3555:  3529:Nature 3503:  3493:  3452:  3442:  3401:  3391:  3352:  3342:  3300:  3259:  3215:  3205:  3151:  3141:  3102:  3061:  3007:  2997:  2953:  2945:  2909:  2899:  2849:  2839:  2800:  2790:  2764:Nature 2743:  2708:  2667:  2657:  2631:Nature 2610:  2600:  2561:  2551:  2512:  2502:  2454:  2413:  2403:  2362:  2352:  2300:  2290:  2249:  2239:  2196:  2188:  2178:  2129:  2041:  2033:  2006:Nature 1985:  1977:  1939:  1929:  1863:  1855:  1814:  1752:innate 1735:, and 1482:, and 1433:Asthma 1390:dermis 1358:, and 1285:, and 1268:Bcl-xL 1266:, and 1216:from. 1214:escape 1154:IL-7Ra 1106:anergy 928:Bcl11b 808:IL-17F 804:IL-17A 794:, and 780:c- Kit 776:RANK-L 720:GM-CSF 715:IL- 1β 696:spleen 618:, and 583:, and 571:, and 514:CD200R 483:TNF- α 356:RANK-L 352:CXCL13 329:GM-CSF 138:, and 116:asthma 6590:Naïve 6498:Pre-B 6493:Naïve 6371:S2CID 6343:(PDF) 6321:S2CID 6233:30239 6229:S2CID 6186:S2CID 5980:S2CID 5671:S2CID 5584:S2CID 5432:S2CID 5232:S2CID 4409:S2CID 4360:S2CID 4268:S2CID 3983:S2CID 3939:S2CID 3890:S2CID 3847:S2CID 3708:S2CID 2951:S2CID 2194:S2CID 2039:S2CID 1983:S2CID 1861:S2CID 1737:CXCR6 1733:CD49a 1722:RORγt 1451:fungi 1295:NKG2D 1291:TRAIL 1264:Bcl-2 1256:CD226 1230:ILC3s 1223:ILC2s 1210:MDSCs 1110:ileum 1082:flora 924:RUNX3 916:TCF-1 912:NFIL3 892:E-box 827:CD30L 800:OX40L 792:CD127 728:NKp30 711:RORγt 670:IL-10 666:KLRG1 646:GATA3 628:CD161 616:CD161 608:KLRG1 604:CRTH2 585:IL-33 577:IL-25 573:IL-13 523:Eomes 519:CD127 510:CD127 506:NKp46 502:NKp44 498:NK1.1 463:IL-18 459:IL-12 455:IL-15 451:T-bet 447:IFN-γ 436:tumor 432:virus 400:IL-22 396:IL-17 366:IL-23 362:IL-1B 325:IL-17 321:IL-22 306:IL-23 302:IL-1B 283:Mucus 268:IL-13 242:IL-33 238:IL-25 184:IL-1B 181:IL-15 177:IL-12 157:Cell 88:ILC3s 84:ILC2s 80:ILC1s 6550:αβ ( 6507:cell 6363:PMID 6313:PMID 6278:PMID 6221:PMID 6178:PMID 6134:PMID 6083:PMID 6039:PMID 5972:PMID 5931:PMID 5879:PMID 5828:PMID 5804:2014 5777:PMID 5720:PMID 5663:PMID 5620:PMID 5576:PMID 5541:PMID 5481:PMID 5424:PMID 5383:PMID 5334:PMID 5283:PMID 5224:PMID 5206:Cell 5183:PMID 5132:PMID 5091:PMID 5032:PMID 4981:PMID 4930:PMID 4870:PMID 4814:PMID 4758:PMID 4709:PMID 4658:PMID 4607:PMID 4566:PMID 4507:PMID 4458:PMID 4401:PMID 4352:PMID 4317:PMID 4291:Cell 4260:PMID 4222:PMID 4178:PMID 4127:PMID 4092:PMID 4040:PMID 3975:PMID 3931:PMID 3913:Cell 3882:PMID 3839:PMID 3759:PMID 3700:PMID 3665:PMID 3614:PMID 3563:PMID 3501:PMID 3450:PMID 3399:PMID 3350:PMID 3298:PMID 3257:PMID 3239:Cell 3213:PMID 3149:PMID 3100:PMID 3059:PMID 3005:PMID 2943:PMID 2907:PMID 2847:PMID 2798:PMID 2741:PMID 2706:PMID 2665:PMID 2608:PMID 2559:PMID 2510:PMID 2452:PMID 2411:PMID 2383:Cell 2360:PMID 2298:PMID 2247:PMID 2186:PMID 2127:PMID 2108:Cell 2031:PMID 1975:PMID 1937:PMID 1853:PMID 1812:PMID 1754:and 1629:PGD2 1586:and 1346:and 1277:and 1063:CCR9 1015:AREG 958:and 932:Gfi1 920:ETS1 819:AIRE 796:CD90 788:CD25 784:CCR6 755:and 732:CD56 730:and 660:and 658:Thy1 644:and 642:RORα 635:IL-7 624:CD44 620:CD25 612:SST2 598:and 581:TSLP 569:IL-5 565:IL-4 554:ILC2 532:and 504:and 384:RANK 369:IL-6 276:AREG 272:IL-9 264:IL-5 260:IL-4 245:TSLP 199:IFN- 118:and 54:and 24:ILCs 6505:reg 6355:doi 6305:doi 6268:PMC 6260:doi 6213:doi 6168:doi 6124:PMC 6114:doi 6110:198 6073:doi 6029:PMC 6019:doi 6007:107 5964:doi 5921:PMC 5913:doi 5869:PMC 5859:doi 5818:PMC 5808:doi 5767:PMC 5759:doi 5747:491 5710:PMC 5702:doi 5655:doi 5643:442 5612:doi 5608:121 5568:doi 5531:PMC 5523:doi 5511:331 5471:PMC 5463:doi 5414:doi 5373:PMC 5365:doi 5324:PMC 5314:doi 5273:PMC 5263:doi 5214:doi 5210:174 5173:PMC 5163:doi 5122:doi 5118:210 5081:PMC 5071:doi 5059:359 5022:PMC 5012:doi 5008:210 4971:PMC 4961:doi 4920:PMC 4912:doi 4900:519 4860:PMC 4850:doi 4804:PMC 4794:doi 4748:doi 4699:PMC 4689:doi 4648:hdl 4638:doi 4597:doi 4593:188 4556:PMC 4548:doi 4497:PMC 4489:doi 4485:185 4448:PMC 4440:doi 4393:doi 4344:doi 4307:PMC 4299:doi 4295:164 4252:doi 4214:doi 4168:PMC 4158:doi 4119:doi 4082:PMC 4074:doi 4070:345 4030:PMC 4022:doi 4010:535 3967:doi 3921:doi 3917:126 3874:doi 3831:doi 3749:PMC 3739:doi 3692:doi 3655:PMC 3645:doi 3641:360 3604:PMC 3594:doi 3553:PMC 3545:doi 3533:484 3491:PMC 3481:doi 3440:PMC 3430:doi 3389:PMC 3381:doi 3340:PMC 3332:doi 3288:doi 3247:doi 3243:157 3203:PMC 3193:doi 3189:348 3139:PMC 3131:doi 3090:doi 3049:doi 2995:PMC 2985:doi 2981:206 2935:doi 2897:PMC 2887:doi 2837:PMC 2829:doi 2788:PMC 2780:doi 2768:464 2733:doi 2696:doi 2655:PMC 2647:doi 2635:464 2598:PMC 2590:doi 2549:PMC 2541:doi 2500:PMC 2490:doi 2442:doi 2438:192 2401:PMC 2391:doi 2387:171 2350:PMC 2340:doi 2288:PMC 2278:doi 2237:PMC 2227:doi 2223:211 2176:PMC 2168:doi 2117:doi 2113:174 2023:doi 2011:494 1967:doi 1927:PMC 1917:doi 1843:doi 1804:doi 1547:IBD 1545:of 1260:ATP 1129:RET 1088:or 940:Tox 936:AhR 900:HEB 896:E2A 888:ID2 840:ID2 812:TNF 662:ST2 457:or 388:TNF 66:or 60:RAG 6792:: 6652:γδ 6626:VM 6618:RM 6610:EM 6602:CM 6582:/ 6580:17 6574:/ 6566:/ 6563:FH 6559:/ 6369:. 6361:. 6351:13 6349:. 6345:. 6319:. 6311:. 6301:41 6299:. 6276:. 6266:. 6256:18 6254:. 6250:. 6227:. 6219:. 6209:18 6207:. 6184:. 6176:. 6164:41 6162:. 6158:. 6146:^ 6132:. 6122:. 6108:. 6104:. 6081:. 6069:43 6067:. 6063:. 6051:^ 6037:. 6027:. 6017:. 6005:. 6001:. 5978:. 5970:. 5960:17 5958:. 5943:^ 5929:. 5919:. 5909:19 5907:. 5903:. 5891:^ 5877:. 5867:. 5853:. 5849:. 5826:. 5816:. 5802:. 5798:. 5775:. 5765:. 5757:. 5745:. 5741:. 5718:. 5708:. 5698:15 5696:. 5692:. 5669:. 5661:. 5653:. 5641:. 5618:. 5606:. 5582:. 5574:. 5564:35 5562:. 5539:. 5529:. 5521:. 5509:. 5505:. 5493:^ 5479:. 5469:. 5459:20 5457:. 5453:. 5430:. 5422:. 5410:28 5408:. 5404:. 5381:. 5371:. 5359:. 5355:. 5332:. 5322:. 5310:40 5308:. 5304:. 5281:. 5271:. 5259:11 5257:. 5253:. 5230:. 5222:. 5208:. 5204:. 5181:. 5171:. 5159:10 5157:. 5153:. 5130:. 5116:. 5112:. 5089:. 5079:. 5069:. 5057:. 5053:. 5030:. 5020:. 5006:. 5002:. 4979:. 4969:. 4957:23 4955:. 4951:. 4928:. 4918:. 4910:. 4898:. 4894:. 4882:^ 4868:. 4858:. 4846:52 4844:. 4840:. 4826:^ 4812:. 4802:. 4790:20 4788:. 4784:. 4770:^ 4756:. 4746:. 4734:. 4730:. 4707:. 4697:. 4685:10 4683:. 4679:. 4656:. 4646:. 4634:30 4632:. 4628:. 4605:. 4591:. 4587:. 4564:. 4554:. 4544:75 4542:. 4538:. 4505:. 4495:. 4483:. 4479:. 4456:. 4446:. 4436:38 4434:. 4430:. 4407:. 4399:. 4387:. 4358:. 4350:. 4338:. 4315:. 4305:. 4293:. 4289:. 4266:. 4258:. 4248:40 4246:. 4234:^ 4220:. 4208:. 4190:^ 4176:. 4166:. 4154:18 4152:. 4148:. 4125:. 4115:36 4113:. 4090:. 4080:. 4068:. 4064:. 4052:^ 4038:. 4028:. 4020:. 4008:. 4004:. 3981:. 3973:. 3961:. 3937:. 3929:. 3915:. 3911:. 3888:. 3880:. 3870:14 3868:. 3845:. 3837:. 3827:17 3825:. 3771:^ 3757:. 3747:. 3735:10 3733:. 3729:. 3706:. 3698:. 3688:14 3686:. 3663:. 3653:. 3639:. 3635:. 3612:. 3602:. 3590:50 3588:. 3584:. 3561:. 3551:. 3543:. 3531:. 3527:. 3513:^ 3499:. 3489:. 3477:10 3475:. 3471:. 3448:. 3438:. 3426:48 3424:. 3420:. 3397:. 3387:. 3377:13 3375:. 3371:. 3348:. 3338:. 3328:16 3326:. 3322:. 3310:^ 3296:. 3284:10 3282:. 3278:. 3255:. 3241:. 3237:. 3225:^ 3211:. 3201:. 3187:. 3183:. 3161:^ 3147:. 3137:. 3127:33 3125:. 3121:. 3098:. 3084:. 3080:. 3057:. 3045:21 3043:. 3039:. 3017:^ 3003:. 2993:. 2979:. 2975:. 2963:^ 2949:. 2941:. 2931:10 2929:. 2905:. 2895:. 2883:10 2881:. 2877:. 2859:^ 2845:. 2835:. 2825:14 2823:. 2819:. 2796:. 2786:. 2778:. 2766:. 2762:. 2739:. 2729:38 2727:. 2704:. 2692:37 2690:. 2686:. 2663:. 2653:. 2645:. 2633:. 2629:. 2606:. 2596:. 2586:14 2584:. 2580:. 2557:. 2547:. 2535:. 2531:. 2508:. 2498:. 2486:48 2484:. 2480:. 2464:^ 2450:. 2436:. 2432:. 2409:. 2399:. 2385:. 2381:. 2358:. 2348:. 2336:10 2334:. 2330:. 2310:^ 2296:. 2286:. 2272:. 2268:. 2245:. 2235:. 2221:. 2215:. 2192:. 2184:. 2174:. 2166:. 2156:20 2154:. 2148:. 2125:. 2111:. 2105:. 2051:^ 2037:. 2029:. 2021:. 2009:. 1995:^ 1981:. 1973:. 1963:13 1961:. 1949:^ 1935:. 1925:. 1913:10 1911:. 1905:. 1873:^ 1859:. 1851:. 1839:13 1837:. 1833:. 1810:. 1800:30 1798:. 1604:. 1486:. 1478:, 1449:, 1334:. 1297:. 1045:. 930:, 918:, 914:, 806:, 790:, 786:, 782:, 702:, 698:, 672:. 630:. 614:, 610:, 606:, 591:. 579:, 567:, 442:. 398:, 390:, 386:, 358:) 354:, 350:, 323:, 270:, 266:, 262:, 229:) 225:, 221:, 134:, 122:. 98:, 94:, 86:, 82:, 78:, 70:. 6624:T 6616:T 6608:T 6600:T 6586:) 6578:h 6576:T 6572:3 6570:h 6568:T 6561:T 6503:B 6439:e 6432:t 6425:v 6377:. 6357:: 6327:. 6307:: 6284:. 6262:: 6235:. 6215:: 6192:. 6170:: 6140:. 6116:: 6089:. 6075:: 6045:. 6021:: 6013:: 5986:. 5966:: 5937:. 5915:: 5885:. 5861:: 5855:8 5834:. 5810:: 5783:. 5761:: 5753:: 5726:. 5704:: 5677:. 5657:: 5649:: 5626:. 5614:: 5590:. 5570:: 5547:. 5525:: 5517:: 5487:. 5465:: 5438:. 5416:: 5389:. 5367:: 5361:3 5340:. 5316:: 5289:. 5265:: 5238:. 5216:: 5189:. 5165:: 5138:. 5124:: 5097:. 5073:: 5065:: 5038:. 5014:: 4987:. 4963:: 4936:. 4914:: 4906:: 4876:. 4852:: 4820:. 4796:: 4764:. 4750:: 4742:: 4736:6 4715:. 4691:: 4664:. 4650:: 4640:: 4613:. 4599:: 4572:. 4550:: 4513:. 4491:: 4464:. 4442:: 4415:. 4395:: 4389:2 4366:. 4346:: 4340:1 4323:. 4301:: 4274:. 4254:: 4228:. 4216:: 4210:3 4184:. 4160:: 4133:. 4121:: 4098:. 4076:: 4046:. 4024:: 4016:: 3989:. 3969:: 3963:8 3945:. 3923:: 3896:. 3876:: 3853:. 3833:: 3765:. 3741:: 3714:. 3694:: 3671:. 3647:: 3620:. 3596:: 3569:. 3547:: 3539:: 3507:. 3483:: 3456:. 3432:: 3405:. 3383:: 3356:. 3334:: 3304:. 3290:: 3263:. 3249:: 3219:. 3195:: 3155:. 3133:: 3106:. 3092:: 3086:7 3065:. 3051:: 3011:. 2987:: 2957:. 2937:: 2913:. 2889:: 2853:. 2831:: 2804:. 2782:: 2774:: 2747:. 2735:: 2712:. 2698:: 2671:. 2649:: 2641:: 2614:. 2592:: 2565:. 2543:: 2537:5 2516:. 2492:: 2458:. 2444:: 2417:. 2393:: 2366:. 2342:: 2304:. 2280:: 2274:7 2253:. 2229:: 2200:. 2170:: 2162:: 2133:. 2119:: 2045:. 2025:: 2017:: 1989:. 1969:: 1943:. 1919:: 1867:. 1845:: 1818:. 1806:: 1279:C 217:( 201:γ 22:(

Index

innate immune
common lymphoid progenitors
signalling molecules
lymphoid
homeostasis
lymphoid morphology
T cells
B cells
RAG
myeloid
dendritic cells
NK cells
ILC1s
ILC2s
ILC3s
homeostasis
morphogenesis
metabolism
T cells
pathology
allergy
asthma
autoimmune disease
cytokines
notch ligands
circadian rhythm
Tumours
IL-12
IL-15
IL-1B

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.